US20100049289A1 - Tissue anchor - Google Patents
Tissue anchor Download PDFInfo
- Publication number
- US20100049289A1 US20100049289A1 US12/558,143 US55814309A US2010049289A1 US 20100049289 A1 US20100049289 A1 US 20100049289A1 US 55814309 A US55814309 A US 55814309A US 2010049289 A1 US2010049289 A1 US 2010049289A1
- Authority
- US
- United States
- Prior art keywords
- anchor
- mesh
- electrode
- lead
- distal end
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
- A61N1/0558—Anchoring or fixation means therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36007—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of urogenital or gastrointestinal organs, e.g. for incontinence control
Definitions
- Embodiments of the present invention generally relate to an anchor that facilitates securing devices or components to internal tissue of a patient and preventing migration of the devices or components from their intended location relative to the tissue of the patient.
- Implantable electronic stimulator devices such as neuromuscular stimulation devices, have been disclosed for use in the treatment of various pelvic conditions, such as urinary incontinence, fecal incontinence and sexual dysfunction.
- Such devices generally include one or more electrodes that are coupled to a control unit by electrode leads. Electrical signals are applied to the desired pelvic tissue of the patient through the electrode leads in order to treat the condition of the patient.
- the electrode leads are typically secured to the tissue using an anchor in the form of a helical coil.
- Exemplary implantable electronic stimulator devices and uses of the devices are disclosed in U.S. Pat. Nos. 6,354,991, 6,652,449, 6,712,772 and 6,862,480, each of which is hereby incorporated by reference in its entirety.
- Urinary incontinence in women has been treated by a surgical method involving the placement of a sling to stabilize or support the bladder neck or urethra of the patient.
- a surgical method involving the placement of a sling to stabilize or support the bladder neck or urethra of the patient.
- Varieties of sling procedures are described in U.S. Pub. No. 2002-016382 A1, which is incorporated herein by reference in its entirety.
- One type of sling procedure is a pubovaginal sling procedure, which is a minimally invasive surgical method involving the placement (e.g. by the use of a Stamey needle or other ligature carrier) of a sling to stabilize or support the bladder neck or urethra. This procedure does not utilize bone anchors. Rather the sling is anchored in the abdominal or rectus fascia.
- U.S. Pub. No. 2007-0260288 A1 which is incorporated herein by reference in its entirety, generally describes a combination of the above devices.
- One or more electrodes are attached to a mechanical support, such as a sling, that supports a portion of the urethra of the patient.
- the electrodes are configured to contact tissue of the patient when the mechanical support is implanted in the patient.
- a control unit drives the electrodes to apply a current to the tissue that treats a pelvic condition of the patient.
- the above-describe devices utilize anchors to secure components of the devices, such as electrode leads and/or mechanical supports, in tissue of the patient. It is desirable, for example, that such anchors prevent relative movement between the anchor and the tissue in which the anchor in embedded, are easy to install in the tissue, avoid damaging the tissue during the implantation procedure, operate as electrical stimulators, can be temporarily moved relative to the tissue without significant restriction by the anchor during installation, can be removed without significantly damaging the tissue, and/or have other features or benefits recognized by those skilled in the art.
- Embodiments of the invention generally relate to an anchor used to secure a position of a device or component relative to internal tissue of a patient and prevent migration of the component relative to the tissue of the patient.
- the anchor is combined with an electrode lead that is configured for implantation in a patient.
- the electrode lead comprises a lead body having a proximal end and a distal end, a stimulating electrode and an anchor.
- the stimulating electrode is attached to the lead body at the distal end.
- the anchor is attached to the distal end of the lead body and comprises an anchor body and mesh attached to the anchor body.
- FIG. 1 is a side plan view of an exemplary electronic stimulator device, in accordance with the embodiments of the invention.
- FIG. 2 is a schematic illustration of a pelvic treatment apparatus in accordance with embodiments of the invention.
- FIGS. 3-5 are cross-sectional views of a distal end of an exemplary electrode lead that includes one or more tissue anchors in accordance with embodiments of the invention.
- FIG. 6 is an isometric view of an anchor in accordance with embodiments of the invention.
- FIG. 7 is a front cross-sectional view of an anchor in accordance with embodiments of the invention.
- FIG. 8 is a cross-sectional view of a portion of an anchor in accordance with embodiments of the invention.
- FIG. 9A is a side plan view of an anchor in accordance with embodiments of the invention.
- FIG. 9B is a cross-sectional view of the anchor of FIG. 9A taken generally along line B-B.
- FIG. 10A is a front plan view of an anchor in accordance with embodiments of the invention.
- FIG. 10B is a cross-sectional view of the anchor of FIG. 10A taken generally along line B-B.
- FIG. 11A is a front plan view of an anchor in accordance with embodiments of the invention.
- FIG. 11B is a cross-sectional view of the anchor of FIG. 11A taken generally along line B-B.
- FIG. 12 is a cross-sectional view of a portion of an anchor in accordance with embodiments of the invention.
- FIG. 13 is a cross-sectional view of a portion of an anchor illustrating various embodiments of the invention.
- FIGS. 14 and 15 are isometric views of anchors in accordance with embodiments of the invention.
- FIGS. 16A and 16B are isometric views of anchors in accordance with embodiments of the invention.
- FIG. 17 is an isometric view of an anchor in accordance with embodiments of the invention.
- FIG. 18 is a front plan view of an anchor in accordance with embodiments of the invention.
- FIG. 19 is a front plan view of an anchor in an expanded state.
- FIGS. 20A and 20B illustrate a temporary anchor covering in accordance with embodiments of the invention.
- FIGS. 21A and 21B are simplified top plan views of one embodiment of an anchor in opened and closed positions, respectively.
- FIGS. 22A-22C illustrate various stages of deployment of a protruding element of an anchor in accordance with embodiments of the invention.
- FIGS. 23 and 24 are simplified on-axis views of various embodiments of the anchor shown in FIGS. 22A-22C .
- FIGS. 25A and 25B are simplified side views of a hinged anchor respectively in retracted and extended positions in accordance with embodiments of the invention.
- FIGS. 26A and 26B are simplified side views of a hinged anchor respectively in retracted and extended positions in accordance with embodiments of the invention.
- FIG. 27 is a simplified side view of an electrode lead comprising a fixation component in accordance with embodiments of the invention.
- FIG. 28 is a side cross-sectional view of the electrode lead of FIG. 27 taken generally along line 28 - 28 .
- FIG. 29 is a front cross-sectional view of a distal end of an electrode lead installed within a trocar.
- FIG. 30 is a simplified front cross-sectional view of a distal end of an electrode lead comprising a fixation component in accordance with embodiments of the invention.
- FIG. 31 is a partial side view of an installation tool in accordance with embodiments of the invention.
- FIGS. 32-34 are simplified front cross-sectional views of the distal end of an electrode lead illustrating a method of installing the electrode lead within a trocar.
- FIG. 35 is a simplified front cross-sectional view of an electrode lead installed within a trocar along with a tool in accordance with embodiments of the invention.
- FIG. 36 is a side cross-sectional view of FIG. 35 taken generally along line 36 - 36 .
- FIGS. 37-39 illustrate method steps of deploying the distal end of the electrode lead of FIGS. 35 and 36 within tissue of a patient, in accordance with embodiments of the invention.
- FIGS. 40-42 are simplified side views of an electrode lead installation tool in accordance with embodiments of the invention.
- FIG. 43 is a block diagram of a kit in accordance with embodiments of the invention.
- Embodiments of the invention are directed to an anchor that facilitates securing devices or components, such as electrode leads, mechanical supports (e.g., meshes, slings), and other devices or components to internal tissue of a patient, and preventing migration of the devices or components from their intended position.
- securing devices or components such as electrode leads, mechanical supports (e.g., meshes, slings), and other devices or components to internal tissue of a patient, and preventing migration of the devices or components from their intended position.
- the tissue in which the anchor of the present invention may be use includes adipose tissue, muscle tissue or any other tissue of the patient. In one embodiment, the tissue is located in the pelvic region of the patient. In some embodiments, the tissue, in which the anchor is to be embedded, is targeted for electrical stimulation or is adjacent a desired stimulation target site.
- Embodiments of the invention comprise the individual embodiments described below and combinations of two or more of the embodiments described below.
- FIG. 1 is a side plan view of an exemplary electronic stimulator device 100 , with which embodiments of the anchors of the present invention may be used.
- Device 100 is configured for implantation into a pelvic region of a patient to provide muscle and/or nerve stimulation that is used to control and/or treat a pelvic condition of the patient, such as pelvic pain, urinary incontinence, fecal incontinence, erectile dysfunction or other pelvic condition that may be treated through electrical stimulation.
- the device 100 comprises a control unit 102 and one or more electrode leads 104 , a proximal end 106 of which is coupled to the control unit 102 via a connector 108 .
- Each electrode lead 104 comprises a lead body 110 and one or more stimulating electrodes 112 at a distal end 114 of the electrode lead 104 or lead body 110 .
- the lead body 110 insulates electrical wires connecting the control unit 102 to the stimulating electrodes 112 .
- the lead body 110 can be in the form of an insulating jacket typically comprising silicone, polyurethane or other flexible, biocompatible electrically insulating material. Additional electrode leads 104 or physiological sensors may be coupled to the control unit 102 .
- control unit 102 comprises circuitry for processing electrical signals received from the one or more stimulating electrodes 112 or physiological sensors.
- the control unit 102 is also configured to apply an electrical current or waveform to the tissue of the patient that is in contact with the one or more stimulating electrodes 112 .
- the electrode lead 104 can be anchored to pelvic tissue of the patient (e.g., internal urinary sphincter muscle) by means of a tissue anchor 120 , which is formed in accordance with embodiments of the invention described below.
- the anchor 120 operates to secure the position of the distal end 114 of the electrode lead 104 in the desired tissue of the patient.
- the anchor 120 can be coupled to the lead body 110 or the stimulating electrode 112 at a location that is proximate to the distal end 114 of the electrode lead 104 , for example.
- the anchor 120 operates to provide electrical contact between the pelvic tissue of the patient and the one or more stimulation electrodes 112 of the electrode lead 104 .
- the pelvic treatment apparatus 130 can be used to treat, for example, urinary incontinence of a patient, and generally comprises a mechanical support 132 , which can be in the form of a mesh or other mechanical support that is installed to provide support to the neck of the bladder 134 or the urethra of the patient, which are generally indicated at 136 .
- the mechanical support can be configured for implantation by any number of known surgical approaches, for example, a suprapubic approach, a transvaginal approach, a retropubic approach, and a transobturator approach.
- the mechanical support is anchored to pelvic tissue of the patient using one or more anchors 120 of the present invention described below.
- Each anchor 120 can be attached to a cable 138 or directly attached to the mechanical support 132 .
- the pelvic treatment apparatus 130 includes one or more stimulating electrodes 140 that are attached to the mechanical support 132 or extend from the mechanical support 132 on electrode leads (not shown), such as those described above with reference to FIG. 1 .
- a control unit 142 located inside or outside of the patient's body, drives the electrodes 140 to apply a current to a pelvic site and treat, for example, stress incontinence, urge incontinence, urge frequency, erectile dysfunction, or other pelvic dysfunctions.
- FIGS. 3-5 are cross-sectional views of the distal end 114 of an electrode lead 104 that includes one or more anchors or fixation components 120 in accordance with embodiments of the invention. While FIGS. 3-5 specifically illustrate the anchor 120 in use with the electrode lead 104 , it is understood that embodiments of the anchor 120 include its use with other devices and components, such as the mechanical support described above.
- Each anchor 120 generally comprises one or more protruding elements 150 that are attached to an anchor body 152 . It is understood that although exemplary illustrations of the anchors 120 described below comprise multiple protruding elements 150 , it is understood that embodiments of the anchor 120 include anchors having a single protruding element 150 and anchors having different types of protruding elements 150 in accordance with the embodiments described herein.
- Embodiments of the anchor body 152 include the lead body 110 ( FIG. 3 ), the stimulating electrode 112 ( FIG. 4 ), a mechanical support or sling 132 ( FIG. 2 ), a cable 138 ( FIG. 2 ), and a separate component 154 ( FIG. 5 ) that can be attached to the lead body 110 or other component. These embodiments of the anchor body 152 are generally included in each reference to the anchor body 152 .
- the anchor body 152 and the protruding elements 150 can be formed of a wide variety of biocompatible implant materials. Suitable materials for an implant include polymerics, and plastics such as polypropylene, polyethylene, nylon, polyester, biocompatible metals or other suitable biocompatible material.
- the protruding elements 150 of the stimulating electrode 112 are formed of a metallic conductive material, such as that of the stimulating electrode 112 .
- the protruding elements 150 are integral with the anchor body 152 , such as the lead body 110 or the stimulating electrode 112 , as respectively illustrated in FIGS. 3 and 4 .
- the protruding elements 150 are either formed along with the formation of the anchor body 152 or are subsequently fused to the anchor body 152 through a welding or other conventional process.
- the stimulating signals generated by the control unit 102 are discharged into the tissue through the electrically conductive protruding elements 150 .
- the protruding elements 150 are non-integral to the anchor body 152 . That is, the protruding elements 152 are attached to the anchor body 152 using an adhesive, a mechanical fastener or other suitable means.
- the anchor body 152 comprises a component 154 that is used to attach the anchor to the desired electrode body 110 , stimulating electrode 112 , mechanical support 132 or other component.
- the component 154 comprises a hub or sleeve as shown in FIG. 5 , to which one or more of the protruding elements 150 are attached.
- the component 154 can be attached to the lead body 110 ( FIG. 5 ) to the stimulating electrode 112 , the mechanical support 132 , or other component.
- the protruding elements 150 can be attached to the component 154 or formed integral therewith.
- the component 154 comprises a cylindrical hub having a bore 156 having a diameter that is slightly larger than the external diameter the component to which it is attached and concentric thereto, an example of which is the lead body 110 shown in FIG. 5 .
- the cylindrical hub 154 is fixedly attached to a desired portion of the lead body 110 or the stimulating electrode 112 using a biocompatible adhesive or other suitable means.
- the bore 156 of the cylindrical hub 154 is approximately the same or smaller than the external diameter of the lead body 110 or other component to which it is attached, such that the bore 156 of the cylindrical hub 154 compresses the exterior surface 158 of the lead body 110 with sufficient force to maintain the relative positions of the cylindrical hub 154 and the lead body 110 during, and subsequent to, implantation of the electrode lead 104 in the patient.
- the anchor body 152 comprises a spiral tube 160 , from which the one or more protruding elements 150 extend, as shown in FIG. 6 .
- the spiral tube 160 wraps around the lead body 110 , the stimulating electrode 112 , or other component, represented in phantom lines, and is fixed thereto using a biocompatible adhesive or through frictional resistance between the interior surface 162 of the spiral tube 160 and the exterior surface 164 of the lead body or stimulating electrode.
- the anchor body 152 can be formed by the stimulating electrode 112 .
- the stimulating electrode 112 is formed like the anchor body 152 with spiral tube 160 .
- the protruding elements 150 are displaced from each other along the longitudinal axis of the anchor body 152 , as illustrated in FIGS. 3-5 . In another embodiment, at least some of the protruding elements 150 are not displaced from each other along the longitudinal axis 170 . Rather, some of the protruding elements 150 are aligned with a plane 172 that extends perpendicular to the longitudinal axis 170 .
- the protruding elements 150 are angularly aligned such that at least some of the protruding elements 150 are positioned in the same radial plane, such as protruding elements 150 A and 150 B that are aligned with the radial plane 174 A, which extends through the longitudinal axis 170 , as shown in FIG. 7 .
- the protruding elements 150 are angularly displaced from each other by an angle 176 , as shown in FIG. 7 .
- the angle 176 can be selected based on the type of protruding element 150 being used, the number of protruding elements 150 , the type of tissue in which the protruding elements 150 are to be embedded and other factors.
- Exemplary angles 176 include angles that result in the equal angular displacement of the protruding elements 150 that are in the same plane 172 that is perpendicular to the longitudinal axis 170 , such as 90 degrees for the exemplary embodiment illustrated in FIG. 7 .
- the angles 176 between the protruding elements are non-uniform. This may be useful when there is a side of the lead body 110 that will be in close proximity to tissue that you do not wish to contact with a protruding element 150 , for example.
- the protruding elements 150 that are longitudinally displaced from each other are angularly staggered such that they do not lie in the same radial plane that is in line with the longitudinal axis.
- one or more protruding elements 150 A and 150 B may be positioned in the radial plane 174 A while one or more other protruding elements 150 C and 150 D, which are longitudinally displaced from the protruding elements 150 A and 150 B, are positioned in the radial plane 174 B that is angularly displaced from the radial plane 174 A by the angle 178 , as illustrated in FIG. 7 .
- the one or more protruding elements 150 have a proximal end 180 that is attached to the anchor body 152 and a distal end 182 that is displaced from the anchor body 152 and is configured to embed in the tissue of the patient.
- the distal end 182 of the protruding element 150 is angled toward a proximal side 184 of the anchor 120 corresponding to the proximal end 106 of the electrode lead 104 , as illustrated by protruding element 150 A of FIG. 8 .
- the distal end 182 of the protruding element 150 is angled toward the distal side 186 of the anchor 120 corresponding to the distal end 114 of the electrode lead 104 , as illustrated by protruding element 150 B in FIG. 8 .
- the anchor 120 includes a combination of protruding elements 150 having distal ends 182 that are angled toward the proximal side 184 and the distal side 186 of the anchor 120 , as shown in FIG. 8 .
- the protruding elements 150 extend radially from the anchor body 152 and operate to secure the position of the electrode lead 104 relative to the tissue in which it is embedded.
- the radially extending protruding element or elements 150 of the anchor 120 resist movement of the electrode lead 104 in the longitudinal direction defined by the longitudinal axis 170 of the electrode lead 104 relative to the tissue in which the electrode lead 104 is embedded.
- Embodiments of the protruding elements 150 can also operate to inhibit or prevent the electrode lead 104 from twisting relative to the tissue in which it is embedded.
- the protruding element 150 is flexible and can be compressed radially toward the anchor body 152 .
- This compressibility of the protruding element or elements 150 allows the anchor 120 to be received within an introducer for deployment into the desired tissue of the patient. Additionally, this flexibility can provide a stress relief from forces that drive movement of the anchor 120 relative to the tissue in which the anchor 120 is embedded and can avoid or reduce the likelihood of tearing the tissue. Further, the flexibility of the protruding element 150 can drive the stimulating electrode back to its intended position relative to the tissue in response to small movements of the stimulating electrode 112 .
- the protruding element 150 comprises a tine 190 , exemplary illustrations of which are shown in FIGS. 3-8 .
- the tine 190 is preferably flexible, but can also be formed to be rigid. In one embodiment, the tine 90 is bowed slightly as shown in FIG. 8 .
- the protruding element 150 comprises a disk 192 that extends radially from the anchor body 152 , as illustrated in the side plan view of FIG. 9A and the cross-sectional view of FIG. 9B taken generally along line B-B of FIG. 9A .
- the one or more disks 192 are flexible and hold the electrode lead 104 in the tissue of the patient like plunger seal. The diameter and thickness of the disks 192 can be selected to provide the desired fixation performance.
- the anchor 120 comprise an umbrella-shaped cup 194 , as illustrated in the front plan view of FIG. 10A and the cross-sectional view of FIG. 10B , which is taken generally along line B-B of FIG. 10A .
- the protruding element 150 comprises a cone-shaped cup 196 , as illustrated in the front plan view of FIG. 11A and the side-cross sectional view of FIG. 11B , which is generally taken along line B-B of FIG. 11A .
- the cups 194 and 196 can be reinforced by ribs 198 , which limit the amount the cups 194 or 196 flex in response to movement relative to the tissue in which they are embedded.
- the reinforcing ribs 198 can be formed integrally with the cups 194 or 196 , extend between an exterior surface 200 and the anchor body 152 ( FIG. 10B ), or extend between an interior surface 202 and the anchor body 152 ( FIG. 11B ).
- the anchor 120 includes one or more protruding elements 150 in the form of barbs 204 , as illustrated in the cross-sectional view of a portion of the anchor 120 provided in FIG. 12 .
- the barbs 204 are generally smaller than the tines 190 and are preferably disposed about the surface of the anchor body 152 in greater numbers than the tines 190 .
- the reduced gripping power that the barbs 204 have as a result of the shorter depth to which they extend into the tissue of the patient is preferably offset by greater numbers of barbs 204 .
- the protruding element or elements 150 comprise shaped bumps 206 or ridges 208 , as illustrated in the side-cross sectional view of FIG. 13 .
- the bumps 206 generally provide a surface texture to the anchor body 152 that can increase the slip resistance between the anchor 120 and the tissue, in which the anchor 120 is embedded.
- the ridges 208 can be shaped similarly to the cups 194 and 196 but are generally smaller and do not extend as far radially from the anchor body 152 .
- the bumps 206 and the ridges 208 are annular and, thus, extend around the circumference of the anchor body 152 .
- FIG. 14 is an isometric view of an anchor 120 in accordance with another embodiment of the invention, in which the protruding elements 150 are in the form of bristles or brush-like protrusions 210 .
- the bristles 210 can be similar to those typically found in test tube or bottle brushes.
- Embodiments of the protruding elements 210 include orienting the bristles such that they are substantially perpendicular to the longitudinal axis 170 , or angling the protruding elements 210 toward the proximal side 184 , and/or the distal side 186 of the anchor 120 .
- FIG. 15 is an isometric view of an anchor 120 in accordance with another embodiment of the invention, in which the protruding elements 150 are in the form of fiber loops 212 that are disposed about the exterior surface of the anchor body 152 .
- the fibrous loops 212 are similar to Velcro® or DuoLock® like material, or are of a hook and loop design.
- FIGS. 16A and 16B are isometric views of anchors 120 , in which the protruding elements 150 comprises a spiraling thread 214 .
- the thread 214 operates like a screw that can be screwed into the tissue of the patient by rotating the anchor 120 in the appropriate direction.
- the thread 214 extends radially from the anchor body 152 at an angle 216 that is approximately perpendicular to the longitudinal axis 170 of the anchor body 152 , as shown in FIG. 16A .
- the thread 214 extends from the anchor body 152 at an acute angle 218 relative to the longitudinal axis 170 .
- the threads 214 are formed of a rigid plastic or other biocompatible material.
- the threads 214 are formed of a flexible material that allows the threads 214 to flex with motion of the tissue.
- FIG. 17 is an isometric view of an anchor 120 in accordance with another embodiment of the invention, in which the protruding element 150 is in the form of a mesh sleeve 220 .
- the mesh sleeve 220 preferably extends around the circumference of the anchor body 152 and can be concentric thereto.
- the size of the openings or pores of the mesh sleeve 220 are preferably sufficient to allow tissue in-growth and fixation within the surrounding tissue.
- the mesh can be made from polypropylene, for example.
- a mesh material 222 is integrally formed with the anchor body 152 , as illustrated in FIG. 18 .
- the anchor body 152 comprises an expandable stent like mesh 224 that is formed of a flexible material or plastic, as shown in the side plan view of FIG. 19 , in which the expandable stent like mesh 224 is shown in an expanded state.
- the expandable stent like mesh 224 is placed in a compact state, similar to that illustrated in FIG. 18 .
- the expandable stent like mesh 224 can be expanded in accordance with conventional techniques into the tissue of the patient.
- the expansion of the stent 224 provides immediate resistance to movement of the anchor 120 relative to the tissue. Over time, the tissue of the patient is allowed to grow within the pores of the mesh material, which further secures the anchor 120 to the tissue of the patient.
- the protruding elements 150 of the anchor 120 are either partially or completely covered by a material that allows for the temporary repositioning of the anchor 120 relative to the tissue of the patient. This is particularly useful where the protruding elements are not compatible with an introducer or are relatively inflexible.
- the protruding elements 150 of the anchor 120 are wrapped in a sheath 226 , as shown in the side cross-sectional view of FIG. 20A .
- the sheath 226 prevents the protruding elements 150 from gripping the tissue of the patient as the anchor 120 is moved in either the forward or rearward direction along the longitudinal axis 170 of the anchor body 152 .
- the sheath operates to compress the protruding elements 150 toward the anchor body 152 , which reduces the cross-sectional area of the anchor 120 and allows for easier insertion and repositioning of the anchor 120 within the tissue of the patient.
- the sheath 226 can be removed after the anchor 120 or stimulating electrode 112 is placed in the desired position.
- the sheath 226 includes a longitudinal slit that simplifies its removal.
- a wire or other component is used to pull out the sheath 226 or generate a longitudinal slit in sheath 226 after the implantation of the electrode anchor body 152 . After the sheath is removed or absorbed by the patient, the protruding elements spring open to an expanded position and embed into the tissue of the patient.
- the sheath 226 is formed of a material that is absorbable by the patient. Once the anchor body 120 or the stimulating electrode 112 is place in the desired position within the patient, the sheath 226 is absorbed by the body and the protruding elements 150 are allowed to become embedded within tissue of the patient.
- an absorbable material 228 is positioned at least about the protruding elements 150 to prevent the protruding elements 150 from snagging the tissue of the patient.
- the material 228 allows the anchor 120 to be moved in either direction along the longitudinal axis 170 within the tissue of the patient. After the anchor 120 is placed in the desired position within the tissue of the patient, the absorbable material gets absorbed by the patient over time and the protruding elements become embedded in the tissue of the patient.
- the anchor 120 illustrated in the top plan views of FIGS. 21A and 21B comprises a pair of protruding elements 150 that can be placed in an expanded position 230 , which is illustrated in FIG. 21A , and a closed or clamping position 232 , which is illustrated in FIG. 21B .
- the anchor 120 is driven into the tissue 234 of the patient while in the expanded position 230 .
- the protruding elements 150 of the anchor 120 are brought together to the clamping position 232 and the tissue is pinched between the protruding elements 150 .
- the protruding elements 150 grip the tissue 234 and secure the anchor 120 to the tissue 234 .
- one or more stimulating electrodes 112 are located at the distal end 182 of at least one of the protruding elements 150 and are configured to apply electrical stimulation to the tissue 234 that is generated by the control unit 102 described above.
- FIGS. 22A-C illustrate an anchor 120 in accordance with another embodiment of the invention, in which the protruding element or elements 150 comprise a fine wire 240 that extends out of a lumen 242 that is formed in the anchor body 152 .
- the wire 240 is initially in a retracted position, shown in FIG. 22A , in which the wire 240 is either slightly extended out of the lumen 242 (as shown) or fully retracted within the lumen 242 .
- This arrangement allows the anchor 120 to be fed into the tissue of the patient. Once the anchor 120 is in the desired position within the tissue of the patient, the wire 240 can be extended out of the lumen 242 and into the tissue, as illustrated in FIG. 22B .
- the wire 240 coils as it is fed into the tissue of the patient, as illustrated in FIG. 22C .
- the wire 240 is formed of a memory shaped material, such as nickel titanium (i.e., NITINOL), that forces the wire 240 to follow a coil trajectory through the surrounding tissue of the patient as it is extended from the lumen 242 .
- Embodiments of the anchor 120 include one or more wires 240 .
- the wires 240 can be angularly displaced about the surface of the anchor body 120 , as illustrated in the on-axis view of FIG. 23 .
- the wires 240 are configured to coil around the anchor body 152 , as illustrated in the on-axis view of FIG. 24 .
- FIGS. 25A and 25B are side plan views of an embodiment of a protruding element 150 respectively in a retracted position 244 and an extended position 246 .
- the distal end 182 of the protruding element 150 lies in close proximity to the exterior surface 248 of the anchor body 152 .
- the protruding element 150 is flexible and is configured to bend at a portion 250 that is adjacent to the proximal end 180 .
- a protruding element 150 can move to this retracted position 244 automatically in response to the feeding of the anchor 120 through the tissue of the patient or by placing the anchor 120 in a tube of an introducer, for example.
- the anchor body 152 can be pulled toward the proximal side 184 .
- the distal end 182 of the protruding element 150 snags a portion of the tissue of the patient and the protruding element 150 is driven to the extended position 246 shown in FIG. 25B .
- the protruding element 150 can reach the fully extended position 246 .
- a stop member 252 is positioned to limit the distance that the distal end 182 of the protruding element 150 can move toward the distal side 186 .
- the stop member 252 defines the fully extended position 246 for the protruding element 150 .
- FIGS. 26A and 26B respectively illustrate another embodiment of a protruding element 150 having a retracted position 244 and an extended position 246 .
- the protruding element 150 is coupled to the anchor body 152 by a hinge 254 .
- the protruding element 150 is allowed to pivot about the hinge 254 between the retracted position 244 shown in FIG. 26A and the extended position 246 shown in FIG. 26B .
- the protruding element 150 shown in FIGS. 26A and 26B moves from the retracted position 244 to the extended position 246 in response to movement of the anchor body 152 toward the proximal side 184 or during the slight withdrawal of the anchor 120 from the tissue of the patient.
- FIG. 27 illustrates a simplified side view of a distal end 114 of an electrode lead 104 having a lead body 110 that includes an anchor 257 , in accordance with embodiments of the invention, that is implanted in tissue 258 of the patient.
- FIG. 28 provides a cross-sectional view of the anchor 257 taken generally along line 28 - 28 of FIG. 27 and illustrates the implantation of the distal end 114 of the electrode adjacent a structure 259 of the patient.
- one embodiment of the electrode lead 104 comprises one or more electrodes 112 , each located at a distal end 114 of the lead body 110 .
- the electrodes 112 may be separated by an insulating element 267 , which may comprise the lead body 110 .
- the anchor 257 comprises an anchor body 152 in accordance with the embodiments described above, such as the lead body 110 ( FIG. 27 ), and a section of mesh 260 attached to the anchor body 152 .
- the anchor 257 is located at the distal end 114 of the electrode lead 104 .
- the bio-compatible mesh 260 is preferably an open matrix mesh, such as a mesh constructed of polypropylene monofilament.
- the mesh 260 comprises one or more mesh sections or wings, such as wings 261 and 262 .
- the mesh 260 has a compact state and an expanded state. In general, at least a portion of the mesh 260 is displaced a greater distance from the anchor body 152 when in the expanded state than when in the compact state.
- the anchor 257 is generally in a form suitable for implantation in the tissue 258 when the mesh 260 is in the compact state and performs its anchoring function in the tissue 258 when the mesh 260 is in the expanded state, such as described above with regard to FIG. 19 .
- the mesh 260 has a shape memory that drives the mesh to a preset expanded, quiescent shape, in which at least a portion of the mesh 260 extends away from the anchor body 152 and into the surrounding tissue 258 .
- the “quiescent shape” of the mesh 260 is one in which the mesh will naturally return to after being deformed, such as when compressed into a compact state.
- the expanded state of the mesh wings 261 and 262 is one in which the wings 261 and 262 are displaced from each other, such as illustrated FIG. 28 .
- one embodiment of the mesh 260 has a shape memory that encourages separation of the one or more wings, such as wings 261 and 262 , within the tissue 258 .
- the anchor 257 is configured to deliver electrical signals from the control unit to the tissue 258 .
- the mesh 260 comprises the one or more electrodes 112 that are used to deliver electrical signals to the tissue 258 .
- one or more conductive fibers 264 ( FIG. 27 ) are attached to the mesh 260 and conduct electrical signals from one or more of the electrodes 112 of the lead body ( FIG. 27 ), or the control unit 102 , into the tissue 258 .
- the conductive fivers 264 are electrically insulated from the tissue 258 and conduct the electrical signals to one or more electrically conductive nodes or electrodes 266 that are attached to the mesh 260 and deliver the electrical signals to the tissue 258 .
- a portion of the mesh 260 is attached to the distal end 114 of the electrode lead 104 at a location 268 .
- Exemplary means for attaching the mesh 260 to the electrode lead 104 include sutures, glue, anchors, or other suitable bio-compatible methods.
- the attachment location 268 comprises a central portion of the mesh 260 .
- one embodiment of the anchor 257 comprises at least two wings of mesh 261 and 262 that extend from the distal end of the electrode lead 104 at the connection location 268 .
- FIG. 29 is a simplified cross-sectional view of the distal end 114 of the electrode lead 104 having the anchor 257 installed in a delivery trocar 270 that is used to implant the electrode lead 104 in the desired tissue 258 of the patient.
- the mesh 260 of the anchor 257 is placed in the compact state (e.g., rolled up) and installed in the trocar 270 .
- the anchor 257 is deployed from the trocar 270 into the tissue 258 , the mesh 260 expands toward the expanded state or its expanded quiescent shape. Tissue ingrowth secures the mesh 260 to the tissue 258 to anchor the location of the distal end 114 of the electrode lead 104 .
- the mesh 260 comprises the wings 261 and 262
- the wings 261 and 262 compressed into the compact state, as shown in FIG. 29 .
- the mesh wings 261 and 262 extend from the connection point 268 away from the distal end 114 of the electrode lead 104 .
- the mesh sections 261 and 262 move toward the preset expanded quiescent shape and into the tissue 258 , as shown in FIG. 28 .
- Ingrowth of the tissue 258 into the mesh 260 operates to anchor the mesh 260 to the tissue 258 , thereby anchoring the distal end 114 of the electrode lead 104 in the desired position.
- the mesh 260 is deployed in the tissue 258 such that it has a desired orientation relative to the structure 259 of the patient.
- the expansion of the mesh 260 can be directed to a side of the electrode lead 104 such that it expands away from the structure 259 or toward the structure 259 .
- the distal end 114 of the electrode lead 104 can be oriented relative to the urethra 259 such that the mesh 260 is located on a side of the electrode lead 104 that is away from the urethra 259 . This prevents fibrosis around the mesh 260 from interfering with the communication of electrical stimulation signals from the electrode lead 104 to the structure 259 .
- the anchor 257 is initially provided in a sterilized and sealed package, in which the mesh 260 , such as mesh sections 261 and 262 , have a quiescent shape in which they lie substantially flat, as illustrated in the simplified cross-sectional view of FIG. 30 .
- FIG. 31 is a simplified side view of an installation tool 276 in accordance with embodiments of the invention that is used to prepare the anchor 257 for installation within a trocar 270 .
- the tool 276 comprises a forked end 278 that includes prongs 280 and 282 that extend substantially parallel to the longitudinal axis 284 of the tool 276 .
- a gap 286 between the prongs 280 and 282 is configured to receive a distal end 288 of the mesh 260 , as illustrated in the simplified cross-sectional view of FIG. 32 .
- the anchor 257 is prepared for installation within a trocar 270 by placing the end 288 of the mesh 260 through the gap 286 and rotating the tool 276 , such as in the direction indicated by arrow 290 , to roll up the mesh 260 , as illustrated in simplified front cross-sectional views of FIGS. 32 and 33 .
- the distal end 114 of the electrode lead 104 and the anchor 257 can be installed in a trocar 270 , as illustrated in the simplified cross-sectional view of FIG. 34 .
- the end 278 of the tool 276 is disengaged from the mesh 260 either prior to or after the insertion of the distal end 114 within the trocar 270 .
- the mesh 260 expands toward its expanded quiescent shape within the tissue 258 , as discussed above.
- FIGS. 35 and 36 respectively are front and side cross-sectional views of a distal end 114 of the electrode lead 104 comprising the anchor 257 installed within a trocar 270 , in accordance with embodiments of the invention.
- a tool 292 is installed in the trocar 270 to aid in the deployment of the mesh wings 261 and 262 .
- the tool 292 operates to separate the mesh wings 261 and 262 and prevent their entanglement within the trocar 270 .
- the tool 292 is configured to cause or assist in the expansion of the mesh wings 261 and 262 into the tissue 258 after deployment of the distal end 114 into the tissue 258 .
- the trocar 270 is partially retracted, as illustrated in the side cross-sectional view of FIG. 37 .
- the cross-sectional width of the end 284 of the tool 292 is expanded, which drives the mesh wings 261 and 262 away from each other within the tissue 258 , as illustrated in FIG. 38 .
- the distal end 294 of the tool 292 can then be withdrawn into the trocar 270 and removed from the patient through the trocar 270 to complete the implantation of the distal end 114 of the electrode lead 104 within the tissue 258 of the patient, as illustrated in the cross-sectional view of FIG. 39 .
- the cross-sectional width of the end 294 of the tool 292 is reduced prior to its withdrawal from the patient.
- the tool 292 comprises a scissor-like mechanism that expands the effective width of the distal end 294 .
- FIGS. 40-42 are simplified side views of a tool 292 in accordance with embodiments of the invention.
- the tool 292 comprises first and second elongated components 296 and 298 that are respectively coupled to a third component 300 through hinges 302 and 304 .
- the initial width 306 of the tool 292 allows the tool 292 to be received within the trocar 270 , as shown in FIGS. 35 and 36 .
- component 296 is moved relative to component 298 , such as, for example, in the direction indicated by arrow 308 .
- the displacement of the hinge 304 from the hinge 302 in the widthwise direction causes the component 300 to pivot about the hinge 302 relative to the component 298 in the direction indicated by arrow 310 to an expanded position, as shown in FIG. 41 .
- the width 312 of the distal end 294 of the tool 292 in the expanded position is significantly greater than the width 306 . This expansion of the width of the distal end 294 drives the expansion of the mesh wings 261 and 262 , as illustrated in FIG. 38 .
- the component 296 can be further moved relative to the component 298 in a direction indicated by arrow 308 to place the distal end 294 in a compacted state ( FIG. 42 ), in which the tool 292 may either be received again within the trocar 270 , or otherwise removed from the patient, while leaving the distal end 114 of the electrode lead 104 in the desired location within the tissue 258 of the patient.
- FIG. 43 illustrates a kit 320 in accordance with embodiments of the invention.
- the kit includes a package 322 containing components including one or more electrode leads 104 in accordance with one or more of the embodiments described above.
- the kit 320 includes the control unit 102 .
- the kit includes instructions 326 for installing the one or more electrode leads 104 in the patient.
- the instructions 324 include instructions for installing the control unit 102 .
- the one or more electrode leads 104 in the kit 320 include an anchor 326 in accordance with one or more of the embodiments described above, such as anchor 120 or 257 .
- the distal end 114 of the one or more electrode leads are provided pre-installed in a trocar 270 .
- one or more tools such as installation tool 278 or deployment tool 292 , are provided in the kit 320 .
- Embodiments of the instructions 324 include instructions for implanting the distal end 114 of the electrode lead 104 within tissue 258 of the patient using the trocar 270 , tool 278 and/or tool 292 . Such instructions include instructions describing one or more of the method steps discussed above with reference to FIGS. 32-42 .
Abstract
Description
- The present application claims the benefit of U.S. provisional patent application Ser. Nos. 61/096,387 filed Sep. 12, 2008 and 61/160,765 filed Mar. 17, 2009; and the present application is a continuation-in-part of U.S. application Ser. No. 12/170,582 filed Jul. 10, 2008, which in turn claims the benefit of U.S. provisional patent application Ser. No. 60/948,908, filed Jul. 10, 2007. The content of each of the above-referenced applications, is hereby incorporated by reference in its entirety.
- Embodiments of the present invention generally relate to an anchor that facilitates securing devices or components to internal tissue of a patient and preventing migration of the devices or components from their intended location relative to the tissue of the patient.
- Implantable electronic stimulator devices, such as neuromuscular stimulation devices, have been disclosed for use in the treatment of various pelvic conditions, such as urinary incontinence, fecal incontinence and sexual dysfunction. Such devices generally include one or more electrodes that are coupled to a control unit by electrode leads. Electrical signals are applied to the desired pelvic tissue of the patient through the electrode leads in order to treat the condition of the patient. The electrode leads are typically secured to the tissue using an anchor in the form of a helical coil. Exemplary implantable electronic stimulator devices and uses of the devices are disclosed in U.S. Pat. Nos. 6,354,991, 6,652,449, 6,712,772 and 6,862,480, each of which is hereby incorporated by reference in its entirety.
- Urinary incontinence in women has been treated by a surgical method involving the placement of a sling to stabilize or support the bladder neck or urethra of the patient. Varieties of sling procedures are described in U.S. Pub. No. 2002-016382 A1, which is incorporated herein by reference in its entirety. One type of sling procedure is a pubovaginal sling procedure, which is a minimally invasive surgical method involving the placement (e.g. by the use of a Stamey needle or other ligature carrier) of a sling to stabilize or support the bladder neck or urethra. This procedure does not utilize bone anchors. Rather the sling is anchored in the abdominal or rectus fascia.
- U.S. Pub. No. 2007-0260288 A1, which is incorporated herein by reference in its entirety, generally describes a combination of the above devices. One or more electrodes are attached to a mechanical support, such as a sling, that supports a portion of the urethra of the patient. The electrodes are configured to contact tissue of the patient when the mechanical support is implanted in the patient. A control unit drives the electrodes to apply a current to the tissue that treats a pelvic condition of the patient.
- The above-describe devices utilize anchors to secure components of the devices, such as electrode leads and/or mechanical supports, in tissue of the patient. It is desirable, for example, that such anchors prevent relative movement between the anchor and the tissue in which the anchor in embedded, are easy to install in the tissue, avoid damaging the tissue during the implantation procedure, operate as electrical stimulators, can be temporarily moved relative to the tissue without significant restriction by the anchor during installation, can be removed without significantly damaging the tissue, and/or have other features or benefits recognized by those skilled in the art.
- Embodiments of the invention generally relate to an anchor used to secure a position of a device or component relative to internal tissue of a patient and prevent migration of the component relative to the tissue of the patient. In one embodiment, the anchor is combined with an electrode lead that is configured for implantation in a patient. The electrode lead comprises a lead body having a proximal end and a distal end, a stimulating electrode and an anchor. The stimulating electrode is attached to the lead body at the distal end. The anchor is attached to the distal end of the lead body and comprises an anchor body and mesh attached to the anchor body.
- This Summary is provided to introduce a selection of concepts in a simplified form that are further described below in the Detailed Description. This Summary is not indented to identify key features or essential features of the claimed subject matter, nor is it intended to be used as an aid in determining the scope of the claimed subject matter. The claimed subject matter is not limited to implementations that solve any or all disadvantages noted in the Background.
-
FIG. 1 is a side plan view of an exemplary electronic stimulator device, in accordance with the embodiments of the invention. -
FIG. 2 is a schematic illustration of a pelvic treatment apparatus in accordance with embodiments of the invention. -
FIGS. 3-5 are cross-sectional views of a distal end of an exemplary electrode lead that includes one or more tissue anchors in accordance with embodiments of the invention. -
FIG. 6 is an isometric view of an anchor in accordance with embodiments of the invention. -
FIG. 7 is a front cross-sectional view of an anchor in accordance with embodiments of the invention. -
FIG. 8 is a cross-sectional view of a portion of an anchor in accordance with embodiments of the invention. -
FIG. 9A is a side plan view of an anchor in accordance with embodiments of the invention. -
FIG. 9B is a cross-sectional view of the anchor ofFIG. 9A taken generally along line B-B. -
FIG. 10A is a front plan view of an anchor in accordance with embodiments of the invention. -
FIG. 10B is a cross-sectional view of the anchor ofFIG. 10A taken generally along line B-B. -
FIG. 11A is a front plan view of an anchor in accordance with embodiments of the invention. -
FIG. 11B is a cross-sectional view of the anchor ofFIG. 11A taken generally along line B-B. -
FIG. 12 is a cross-sectional view of a portion of an anchor in accordance with embodiments of the invention. -
FIG. 13 is a cross-sectional view of a portion of an anchor illustrating various embodiments of the invention. -
FIGS. 14 and 15 are isometric views of anchors in accordance with embodiments of the invention. -
FIGS. 16A and 16B are isometric views of anchors in accordance with embodiments of the invention. -
FIG. 17 is an isometric view of an anchor in accordance with embodiments of the invention. -
FIG. 18 is a front plan view of an anchor in accordance with embodiments of the invention. -
FIG. 19 is a front plan view of an anchor in an expanded state. -
FIGS. 20A and 20B illustrate a temporary anchor covering in accordance with embodiments of the invention. -
FIGS. 21A and 21B are simplified top plan views of one embodiment of an anchor in opened and closed positions, respectively. -
FIGS. 22A-22C illustrate various stages of deployment of a protruding element of an anchor in accordance with embodiments of the invention. -
FIGS. 23 and 24 are simplified on-axis views of various embodiments of the anchor shown inFIGS. 22A-22C . -
FIGS. 25A and 25B are simplified side views of a hinged anchor respectively in retracted and extended positions in accordance with embodiments of the invention. -
FIGS. 26A and 26B are simplified side views of a hinged anchor respectively in retracted and extended positions in accordance with embodiments of the invention. -
FIG. 27 is a simplified side view of an electrode lead comprising a fixation component in accordance with embodiments of the invention. -
FIG. 28 is a side cross-sectional view of the electrode lead ofFIG. 27 taken generally along line 28-28. -
FIG. 29 is a front cross-sectional view of a distal end of an electrode lead installed within a trocar. -
FIG. 30 is a simplified front cross-sectional view of a distal end of an electrode lead comprising a fixation component in accordance with embodiments of the invention. -
FIG. 31 is a partial side view of an installation tool in accordance with embodiments of the invention. -
FIGS. 32-34 are simplified front cross-sectional views of the distal end of an electrode lead illustrating a method of installing the electrode lead within a trocar. -
FIG. 35 is a simplified front cross-sectional view of an electrode lead installed within a trocar along with a tool in accordance with embodiments of the invention. -
FIG. 36 is a side cross-sectional view ofFIG. 35 taken generally along line 36-36. -
FIGS. 37-39 illustrate method steps of deploying the distal end of the electrode lead ofFIGS. 35 and 36 within tissue of a patient, in accordance with embodiments of the invention. -
FIGS. 40-42 are simplified side views of an electrode lead installation tool in accordance with embodiments of the invention. -
FIG. 43 is a block diagram of a kit in accordance with embodiments of the invention. - Embodiments of the invention are directed to an anchor that facilitates securing devices or components, such as electrode leads, mechanical supports (e.g., meshes, slings), and other devices or components to internal tissue of a patient, and preventing migration of the devices or components from their intended position.
- The tissue in which the anchor of the present invention may be use includes adipose tissue, muscle tissue or any other tissue of the patient. In one embodiment, the tissue is located in the pelvic region of the patient. In some embodiments, the tissue, in which the anchor is to be embedded, is targeted for electrical stimulation or is adjacent a desired stimulation target site. Embodiments of the invention comprise the individual embodiments described below and combinations of two or more of the embodiments described below.
- Initially, exemplary devices or components with which the anchors of the present invention may be used will be discussed.
FIG. 1 is a side plan view of an exemplaryelectronic stimulator device 100, with which embodiments of the anchors of the present invention may be used.Device 100 is configured for implantation into a pelvic region of a patient to provide muscle and/or nerve stimulation that is used to control and/or treat a pelvic condition of the patient, such as pelvic pain, urinary incontinence, fecal incontinence, erectile dysfunction or other pelvic condition that may be treated through electrical stimulation. - In one embodiment, the
device 100 comprises acontrol unit 102 and one or more electrode leads 104, aproximal end 106 of which is coupled to thecontrol unit 102 via aconnector 108. Eachelectrode lead 104 comprises alead body 110 and one or morestimulating electrodes 112 at adistal end 114 of theelectrode lead 104 orlead body 110. Thelead body 110 insulates electrical wires connecting thecontrol unit 102 to the stimulatingelectrodes 112. Thelead body 110 can be in the form of an insulating jacket typically comprising silicone, polyurethane or other flexible, biocompatible electrically insulating material. Additional electrode leads 104 or physiological sensors may be coupled to thecontrol unit 102. - In one embodiment, the
control unit 102 comprises circuitry for processing electrical signals received from the one or morestimulating electrodes 112 or physiological sensors. Thecontrol unit 102 is also configured to apply an electrical current or waveform to the tissue of the patient that is in contact with the one or morestimulating electrodes 112. - The
electrode lead 104 can be anchored to pelvic tissue of the patient (e.g., internal urinary sphincter muscle) by means of atissue anchor 120, which is formed in accordance with embodiments of the invention described below. Theanchor 120 operates to secure the position of thedistal end 114 of theelectrode lead 104 in the desired tissue of the patient. Theanchor 120 can be coupled to thelead body 110 or the stimulatingelectrode 112 at a location that is proximate to thedistal end 114 of theelectrode lead 104, for example. In one embodiment, theanchor 120 operates to provide electrical contact between the pelvic tissue of the patient and the one ormore stimulation electrodes 112 of theelectrode lead 104. - Another device or component with which embodiments of the
anchor 120 may be used is apelvic treatment apparatus 130, an example of which is illustrated inFIG. 2 . Thepelvic treatment apparatus 130 can be used to treat, for example, urinary incontinence of a patient, and generally comprises amechanical support 132, which can be in the form of a mesh or other mechanical support that is installed to provide support to the neck of thebladder 134 or the urethra of the patient, which are generally indicated at 136. The mechanical support can be configured for implantation by any number of known surgical approaches, for example, a suprapubic approach, a transvaginal approach, a retropubic approach, and a transobturator approach. - In one embodiment, the mechanical support is anchored to pelvic tissue of the patient using one or
more anchors 120 of the present invention described below. Eachanchor 120 can be attached to acable 138 or directly attached to themechanical support 132. - In one embodiment, the
pelvic treatment apparatus 130 includes one or morestimulating electrodes 140 that are attached to themechanical support 132 or extend from themechanical support 132 on electrode leads (not shown), such as those described above with reference toFIG. 1 . Acontrol unit 142, located inside or outside of the patient's body, drives theelectrodes 140 to apply a current to a pelvic site and treat, for example, stress incontinence, urge incontinence, urge frequency, erectile dysfunction, or other pelvic dysfunctions. -
FIGS. 3-5 are cross-sectional views of thedistal end 114 of anelectrode lead 104 that includes one or more anchors orfixation components 120 in accordance with embodiments of the invention. WhileFIGS. 3-5 specifically illustrate theanchor 120 in use with theelectrode lead 104, it is understood that embodiments of theanchor 120 include its use with other devices and components, such as the mechanical support described above. - Each
anchor 120 generally comprises one or moreprotruding elements 150 that are attached to ananchor body 152. It is understood that although exemplary illustrations of theanchors 120 described below comprise multipleprotruding elements 150, it is understood that embodiments of theanchor 120 include anchors having a singleprotruding element 150 and anchors having different types of protrudingelements 150 in accordance with the embodiments described herein. - Multiple embodiments of the
anchor 120 that are generally independent of the type of protrudingelement 150 that is employed will initially be discussed with reference toFIGS. 3-5 . Embodiments of theanchor body 152 include the lead body 110 (FIG. 3 ), the stimulating electrode 112 (FIG. 4 ), a mechanical support or sling 132 (FIG. 2 ), a cable 138 (FIG. 2 ), and a separate component 154 (FIG. 5 ) that can be attached to thelead body 110 or other component. These embodiments of theanchor body 152 are generally included in each reference to theanchor body 152. - In one embodiment, the
anchor body 152 and theprotruding elements 150 can be formed of a wide variety of biocompatible implant materials. Suitable materials for an implant include polymerics, and plastics such as polypropylene, polyethylene, nylon, polyester, biocompatible metals or other suitable biocompatible material. In one embodiment, the protrudingelements 150 of the stimulatingelectrode 112 are formed of a metallic conductive material, such as that of the stimulatingelectrode 112. - In one embodiment, the protruding
elements 150 are integral with theanchor body 152, such as thelead body 110 or the stimulatingelectrode 112, as respectively illustrated inFIGS. 3 and 4 . Thus, the protrudingelements 150 are either formed along with the formation of theanchor body 152 or are subsequently fused to theanchor body 152 through a welding or other conventional process. In one embodiment, when the protruding elements are integral with the stimulatingelectrode 112, the stimulating signals generated by thecontrol unit 102 are discharged into the tissue through the electrically conductiveprotruding elements 150. - In one embodiment, the protruding
elements 150 are non-integral to theanchor body 152. That is, the protrudingelements 152 are attached to theanchor body 152 using an adhesive, a mechanical fastener or other suitable means. - As mentioned above, one embodiment of the
anchor body 152 comprises acomponent 154 that is used to attach the anchor to the desiredelectrode body 110, stimulatingelectrode 112,mechanical support 132 or other component. In one embodiment, thecomponent 154 comprises a hub or sleeve as shown inFIG. 5 , to which one or more of theprotruding elements 150 are attached. Thecomponent 154 can be attached to the lead body 110 (FIG. 5 ) to the stimulatingelectrode 112, themechanical support 132, or other component. The protrudingelements 150 can be attached to thecomponent 154 or formed integral therewith. - In one embodiment, the
component 154 comprises a cylindrical hub having abore 156 having a diameter that is slightly larger than the external diameter the component to which it is attached and concentric thereto, an example of which is thelead body 110 shown inFIG. 5 . Thecylindrical hub 154 is fixedly attached to a desired portion of thelead body 110 or the stimulatingelectrode 112 using a biocompatible adhesive or other suitable means. In one embodiment, thebore 156 of thecylindrical hub 154 is approximately the same or smaller than the external diameter of thelead body 110 or other component to which it is attached, such that thebore 156 of thecylindrical hub 154 compresses theexterior surface 158 of thelead body 110 with sufficient force to maintain the relative positions of thecylindrical hub 154 and thelead body 110 during, and subsequent to, implantation of theelectrode lead 104 in the patient. - In one embodiment, the
anchor body 152 comprises aspiral tube 160, from which the one or moreprotruding elements 150 extend, as shown inFIG. 6 . In one embodiment, thespiral tube 160 wraps around thelead body 110, the stimulatingelectrode 112, or other component, represented in phantom lines, and is fixed thereto using a biocompatible adhesive or through frictional resistance between theinterior surface 162 of thespiral tube 160 and theexterior surface 164 of the lead body or stimulating electrode. As mentioned above, theanchor body 152 can be formed by the stimulatingelectrode 112. Thus, it is understood that, in a related embodiment, the stimulatingelectrode 112 is formed like theanchor body 152 withspiral tube 160. - The following discussion of the location and orientation of the
protruding elements 150 in accordance with embodiments of the invention applies to the embodiments described above and is generally independent of the type ofanchor body 152, to which theprotruding elements 150 are attached. In one embodiment, at least some of theprotruding elements 150 are displaced from each other along the longitudinal axis of theanchor body 152, as illustrated inFIGS. 3-5 . In another embodiment, at least some of theprotruding elements 150 are not displaced from each other along thelongitudinal axis 170. Rather, some of theprotruding elements 150 are aligned with aplane 172 that extends perpendicular to thelongitudinal axis 170. - In one embodiment, the protruding
elements 150 are angularly aligned such that at least some of theprotruding elements 150 are positioned in the same radial plane, such asprotruding elements radial plane 174A, which extends through thelongitudinal axis 170, as shown inFIG. 7 . - In one embodiment, the protruding
elements 150 are angularly displaced from each other by anangle 176, as shown inFIG. 7 . Theangle 176 can be selected based on the type of protrudingelement 150 being used, the number ofprotruding elements 150, the type of tissue in which theprotruding elements 150 are to be embedded and other factors.Exemplary angles 176 include angles that result in the equal angular displacement of theprotruding elements 150 that are in thesame plane 172 that is perpendicular to thelongitudinal axis 170, such as 90 degrees for the exemplary embodiment illustrated inFIG. 7 . In one embodiment, theangles 176 between the protruding elements are non-uniform. This may be useful when there is a side of thelead body 110 that will be in close proximity to tissue that you do not wish to contact with aprotruding element 150, for example. - In another embodiment, at least some of the
protruding elements 150 that are longitudinally displaced from each other are angularly staggered such that they do not lie in the same radial plane that is in line with the longitudinal axis. For instance, one or moreprotruding elements radial plane 174A while one or more other protrudingelements elements radial plane 174B that is angularly displaced from theradial plane 174A by theangle 178, as illustrated inFIG. 7 . - In one embodiment, the one or more
protruding elements 150 have aproximal end 180 that is attached to theanchor body 152 and adistal end 182 that is displaced from theanchor body 152 and is configured to embed in the tissue of the patient. In one embodiment, thedistal end 182 of the protrudingelement 150 is angled toward aproximal side 184 of theanchor 120 corresponding to theproximal end 106 of theelectrode lead 104, as illustrated by protrudingelement 150A ofFIG. 8 . In accordance with another embodiment, thedistal end 182 of the protrudingelement 150 is angled toward thedistal side 186 of theanchor 120 corresponding to thedistal end 114 of theelectrode lead 104, as illustrated by protrudingelement 150B inFIG. 8 . In accordance with another embodiment, theanchor 120 includes a combination of protrudingelements 150 having distal ends 182 that are angled toward theproximal side 184 and thedistal side 186 of theanchor 120, as shown inFIG. 8 . - Additional embodiments of the
anchor 120 include various combinations of the above-described embodiments and one or more of the embodiments of theprotruding elements 150 described below. In one embodiment, the protrudingelements 150 extend radially from theanchor body 152 and operate to secure the position of theelectrode lead 104 relative to the tissue in which it is embedded. The radially extending protruding element orelements 150 of theanchor 120 resist movement of theelectrode lead 104 in the longitudinal direction defined by thelongitudinal axis 170 of theelectrode lead 104 relative to the tissue in which theelectrode lead 104 is embedded. Embodiments of theprotruding elements 150 can also operate to inhibit or prevent theelectrode lead 104 from twisting relative to the tissue in which it is embedded. - In one embodiment, the protruding
element 150 is flexible and can be compressed radially toward theanchor body 152. This compressibility of the protruding element orelements 150 allows theanchor 120 to be received within an introducer for deployment into the desired tissue of the patient. Additionally, this flexibility can provide a stress relief from forces that drive movement of theanchor 120 relative to the tissue in which theanchor 120 is embedded and can avoid or reduce the likelihood of tearing the tissue. Further, the flexibility of the protrudingelement 150 can drive the stimulating electrode back to its intended position relative to the tissue in response to small movements of the stimulatingelectrode 112. - One embodiment of the protruding
element 150 comprises atine 190, exemplary illustrations of which are shown inFIGS. 3-8 . Thetine 190 is preferably flexible, but can also be formed to be rigid. In one embodiment, the tine 90 is bowed slightly as shown inFIG. 8 . - One embodiment of the protruding
element 150 comprises a disk 192 that extends radially from theanchor body 152, as illustrated in the side plan view ofFIG. 9A and the cross-sectional view ofFIG. 9B taken generally along line B-B ofFIG. 9A . In one embodiment, the one or more disks 192 are flexible and hold theelectrode lead 104 in the tissue of the patient like plunger seal. The diameter and thickness of the disks 192 can be selected to provide the desired fixation performance. - In another embodiment of the protruding element or
elements 150, theanchor 120 comprise an umbrella-shapedcup 194, as illustrated in the front plan view ofFIG. 10A and the cross-sectional view ofFIG. 10B , which is taken generally along line B-B ofFIG. 10A . In another embodiment, the protrudingelement 150 comprises a cone-shapedcup 196, as illustrated in the front plan view ofFIG. 11A and the side-cross sectional view ofFIG. 11B , which is generally taken along line B-B ofFIG. 11A . Thecups ribs 198, which limit the amount thecups ribs 198 can be formed integrally with thecups FIG. 10B ), or extend between aninterior surface 202 and the anchor body 152 (FIG. 11B ). - In one embodiment, the
anchor 120 includes one or moreprotruding elements 150 in the form ofbarbs 204, as illustrated in the cross-sectional view of a portion of theanchor 120 provided inFIG. 12 . Thebarbs 204 are generally smaller than thetines 190 and are preferably disposed about the surface of theanchor body 152 in greater numbers than thetines 190. The reduced gripping power that thebarbs 204 have as a result of the shorter depth to which they extend into the tissue of the patient is preferably offset by greater numbers ofbarbs 204. - Another embodiment of the protruding element or
elements 150 comprise shapedbumps 206 orridges 208, as illustrated in the side-cross sectional view ofFIG. 13 . Thebumps 206 generally provide a surface texture to theanchor body 152 that can increase the slip resistance between theanchor 120 and the tissue, in which theanchor 120 is embedded. Theridges 208 can be shaped similarly to thecups anchor body 152. In one embodiment, thebumps 206 and theridges 208 are annular and, thus, extend around the circumference of theanchor body 152. -
FIG. 14 is an isometric view of ananchor 120 in accordance with another embodiment of the invention, in which theprotruding elements 150 are in the form of bristles or brush-like protrusions 210. Thebristles 210 can be similar to those typically found in test tube or bottle brushes. Embodiments of theprotruding elements 210 include orienting the bristles such that they are substantially perpendicular to thelongitudinal axis 170, or angling the protrudingelements 210 toward theproximal side 184, and/or thedistal side 186 of theanchor 120. -
FIG. 15 is an isometric view of ananchor 120 in accordance with another embodiment of the invention, in which theprotruding elements 150 are in the form offiber loops 212 that are disposed about the exterior surface of theanchor body 152. The tissue, in which theanchor 120 is embedded, grows around and through the fibrous loops to secure theanchor 120 to the tissue. In one embodiment, thefibrous loops 212 are similar to Velcro® or DuoLock® like material, or are of a hook and loop design. -
FIGS. 16A and 16B are isometric views ofanchors 120, in which theprotruding elements 150 comprises a spiralingthread 214. Thethread 214 operates like a screw that can be screwed into the tissue of the patient by rotating theanchor 120 in the appropriate direction. In one embodiment, thethread 214 extends radially from theanchor body 152 at anangle 216 that is approximately perpendicular to thelongitudinal axis 170 of theanchor body 152, as shown inFIG. 16A . In accordance with another embodiment, thethread 214 extends from theanchor body 152 at anacute angle 218 relative to thelongitudinal axis 170. In one embodiment, thethreads 214 are formed of a rigid plastic or other biocompatible material. In another embodiment, thethreads 214 are formed of a flexible material that allows thethreads 214 to flex with motion of the tissue. -
FIG. 17 is an isometric view of ananchor 120 in accordance with another embodiment of the invention, in which the protrudingelement 150 is in the form of amesh sleeve 220. Themesh sleeve 220 preferably extends around the circumference of theanchor body 152 and can be concentric thereto. The size of the openings or pores of themesh sleeve 220 are preferably sufficient to allow tissue in-growth and fixation within the surrounding tissue. The mesh can be made from polypropylene, for example. - In accordance with another embodiment, a mesh material 222 is integrally formed with the
anchor body 152, as illustrated inFIG. 18 . - In one embodiment of the
anchor 120, theanchor body 152 comprises an expandable stent likemesh 224 that is formed of a flexible material or plastic, as shown in the side plan view ofFIG. 19 , in which the expandable stent likemesh 224 is shown in an expanded state. During the implantation of theanchor 120 in the patient, the expandable stent likemesh 224 is placed in a compact state, similar to that illustrated inFIG. 18 . Once theanchor 120 is in the desired position within the tissue of the patient, the expandable stent likemesh 224 can be expanded in accordance with conventional techniques into the tissue of the patient. The expansion of thestent 224 provides immediate resistance to movement of theanchor 120 relative to the tissue. Over time, the tissue of the patient is allowed to grow within the pores of the mesh material, which further secures theanchor 120 to the tissue of the patient. - In accordance with another embodiment of the invention, the protruding
elements 150 of theanchor 120 are either partially or completely covered by a material that allows for the temporary repositioning of theanchor 120 relative to the tissue of the patient. This is particularly useful where the protruding elements are not compatible with an introducer or are relatively inflexible. - In one embodiment, the protruding
elements 150 of theanchor 120 are wrapped in asheath 226, as shown in the side cross-sectional view ofFIG. 20A . Thesheath 226 prevents the protrudingelements 150 from gripping the tissue of the patient as theanchor 120 is moved in either the forward or rearward direction along thelongitudinal axis 170 of theanchor body 152. In one embodiment, the sheath operates to compress theprotruding elements 150 toward theanchor body 152, which reduces the cross-sectional area of theanchor 120 and allows for easier insertion and repositioning of theanchor 120 within the tissue of the patient. - In one embodiment, the
sheath 226 can be removed after theanchor 120 or stimulatingelectrode 112 is placed in the desired position. In one embodiment, thesheath 226 includes a longitudinal slit that simplifies its removal. In another embodiment, a wire or other component is used to pull out thesheath 226 or generate a longitudinal slit insheath 226 after the implantation of theelectrode anchor body 152. After the sheath is removed or absorbed by the patient, the protruding elements spring open to an expanded position and embed into the tissue of the patient. - In another embodiment, the
sheath 226 is formed of a material that is absorbable by the patient. Once theanchor body 120 or the stimulatingelectrode 112 is place in the desired position within the patient, thesheath 226 is absorbed by the body and theprotruding elements 150 are allowed to become embedded within tissue of the patient. - In accordance with another embodiment, an
absorbable material 228 is positioned at least about the protrudingelements 150 to prevent theprotruding elements 150 from snagging the tissue of the patient. Thematerial 228 allows theanchor 120 to be moved in either direction along thelongitudinal axis 170 within the tissue of the patient. After theanchor 120 is placed in the desired position within the tissue of the patient, the absorbable material gets absorbed by the patient over time and the protruding elements become embedded in the tissue of the patient. - The
anchor 120 illustrated in the top plan views ofFIGS. 21A and 21B comprises a pair of protrudingelements 150 that can be placed in an expandedposition 230, which is illustrated inFIG. 21A , and a closed or clampingposition 232, which is illustrated inFIG. 21B . Initially, theanchor 120 is driven into thetissue 234 of the patient while in the expandedposition 230. Once inserted into the tissue as desired, the protrudingelements 150 of theanchor 120 are brought together to theclamping position 232 and the tissue is pinched between theprotruding elements 150. When in the clamping position, the protrudingelements 150 grip thetissue 234 and secure theanchor 120 to thetissue 234. In one embodiment, one or morestimulating electrodes 112 are located at thedistal end 182 of at least one of theprotruding elements 150 and are configured to apply electrical stimulation to thetissue 234 that is generated by thecontrol unit 102 described above. -
FIGS. 22A-C illustrate ananchor 120 in accordance with another embodiment of the invention, in which the protruding element orelements 150 comprise afine wire 240 that extends out of alumen 242 that is formed in theanchor body 152. In one embodiment, thewire 240 is initially in a retracted position, shown inFIG. 22A , in which thewire 240 is either slightly extended out of the lumen 242 (as shown) or fully retracted within thelumen 242. This arrangement allows theanchor 120 to be fed into the tissue of the patient. Once theanchor 120 is in the desired position within the tissue of the patient, thewire 240 can be extended out of thelumen 242 and into the tissue, as illustrated inFIG. 22B . In one embodiment, thewire 240 coils as it is fed into the tissue of the patient, as illustrated inFIG. 22C . In one embodiment, thewire 240 is formed of a memory shaped material, such as nickel titanium (i.e., NITINOL), that forces thewire 240 to follow a coil trajectory through the surrounding tissue of the patient as it is extended from thelumen 242. Embodiments of theanchor 120 include one ormore wires 240. Thewires 240 can be angularly displaced about the surface of theanchor body 120, as illustrated in the on-axis view ofFIG. 23 . In one embodiment, thewires 240 are configured to coil around theanchor body 152, as illustrated in the on-axis view ofFIG. 24 . - Another embodiment of the
anchor 120 of the present invention comprises one or moreprotruding elements 150 that are configured to have a retracted position, in which thedistal end 182 of the protrudingelement 150 is located in close proximity to theanchor body 152, and an extended position, in which thedistal end 182 is displaced radially from theanchor body 152.FIGS. 25A and 25B are side plan views of an embodiment of aprotruding element 150 respectively in a retractedposition 244 and anextended position 246. When in the retractedposition 244, thedistal end 182 of the protrudingelement 150 lies in close proximity to theexterior surface 248 of theanchor body 152. In one embodiment, the protrudingelement 150 is flexible and is configured to bend at aportion 250 that is adjacent to theproximal end 180. A protrudingelement 150 can move to this retractedposition 244 automatically in response to the feeding of theanchor 120 through the tissue of the patient or by placing theanchor 120 in a tube of an introducer, for example. - Once the
anchor 120 is positioned as desired in the tissue of the patient, theanchor body 152 can be pulled toward theproximal side 184. During this movement of theanchor body 120, thedistal end 182 of the protrudingelement 150 snags a portion of the tissue of the patient and the protrudingelement 150 is driven to theextended position 246 shown inFIG. 25B . With only a slight movement of theanchor body 152 toward theproximal side 184, the protrudingelement 150 can reach the fullyextended position 246. In one embodiment, astop member 252 is positioned to limit the distance that thedistal end 182 of the protrudingelement 150 can move toward thedistal side 186. Thus, thestop member 252 defines the fullyextended position 246 for theprotruding element 150. -
FIGS. 26A and 26B respectively illustrate another embodiment of aprotruding element 150 having a retractedposition 244 and anextended position 246. In accordance with one embodiment, the protrudingelement 150 is coupled to theanchor body 152 by ahinge 254. The protrudingelement 150 is allowed to pivot about thehinge 254 between the retractedposition 244 shown inFIG. 26A and theextended position 246 shown inFIG. 26B . As with the embodiment of the protrudingelement 150 described above with regard toFIGS. 25A and 25B , the protrudingelement 150 shown inFIGS. 26A and 26B moves from the retractedposition 244 to theextended position 246 in response to movement of theanchor body 152 toward theproximal side 184 or during the slight withdrawal of theanchor 120 from the tissue of the patient. -
FIG. 27 illustrates a simplified side view of adistal end 114 of anelectrode lead 104 having alead body 110 that includes ananchor 257, in accordance with embodiments of the invention, that is implanted intissue 258 of the patient.FIG. 28 provides a cross-sectional view of theanchor 257 taken generally along line 28-28 ofFIG. 27 and illustrates the implantation of thedistal end 114 of the electrode adjacent a structure 259 of the patient. - As discussed above, one embodiment of the
electrode lead 104 comprises one ormore electrodes 112, each located at adistal end 114 of thelead body 110. Theelectrodes 112 may be separated by an insulatingelement 267, which may comprise thelead body 110. - One embodiment of the
anchor 257 comprises ananchor body 152 in accordance with the embodiments described above, such as the lead body 110 (FIG. 27 ), and a section ofmesh 260 attached to theanchor body 152. In one embodiment, theanchor 257 is located at thedistal end 114 of theelectrode lead 104. Thebio-compatible mesh 260 is preferably an open matrix mesh, such as a mesh constructed of polypropylene monofilament. In one embodiment, themesh 260 comprises one or more mesh sections or wings, such aswings - In one embodiment, the
mesh 260 has a compact state and an expanded state. In general, at least a portion of themesh 260 is displaced a greater distance from theanchor body 152 when in the expanded state than when in the compact state. Theanchor 257 is generally in a form suitable for implantation in thetissue 258 when themesh 260 is in the compact state and performs its anchoring function in thetissue 258 when themesh 260 is in the expanded state, such as described above with regard toFIG. 19 . - In one embodiment, the
mesh 260 has a shape memory that drives the mesh to a preset expanded, quiescent shape, in which at least a portion of themesh 260 extends away from theanchor body 152 and into the surroundingtissue 258. As used herein, the “quiescent shape” of themesh 260 is one in which the mesh will naturally return to after being deformed, such as when compressed into a compact state. - In one embodiment, the expanded state of the
mesh wings wings FIG. 28 . Thus, one embodiment of themesh 260 has a shape memory that encourages separation of the one or more wings, such aswings tissue 258. - In one embodiment, the
anchor 257 is configured to deliver electrical signals from the control unit to thetissue 258. In one embodiment, themesh 260 comprises the one ormore electrodes 112 that are used to deliver electrical signals to thetissue 258. In one embodiment, one or more conductive fibers 264 (FIG. 27 ) are attached to themesh 260 and conduct electrical signals from one or more of theelectrodes 112 of the lead body (FIG. 27 ), or thecontrol unit 102, into thetissue 258. In one embodiment, theconductive fivers 264 are electrically insulated from thetissue 258 and conduct the electrical signals to one or more electrically conductive nodes orelectrodes 266 that are attached to themesh 260 and deliver the electrical signals to thetissue 258. - A portion of the
mesh 260 is attached to thedistal end 114 of theelectrode lead 104 at alocation 268. Exemplary means for attaching themesh 260 to theelectrode lead 104 include sutures, glue, anchors, or other suitable bio-compatible methods. In one embodiment, theattachment location 268 comprises a central portion of themesh 260. As a result, one embodiment of theanchor 257 comprises at least two wings ofmesh electrode lead 104 at theconnection location 268. -
FIG. 29 is a simplified cross-sectional view of thedistal end 114 of theelectrode lead 104 having theanchor 257 installed in adelivery trocar 270 that is used to implant theelectrode lead 104 in the desiredtissue 258 of the patient. In one embodiment, themesh 260 of theanchor 257 is placed in the compact state (e.g., rolled up) and installed in thetrocar 270. When theanchor 257 is deployed from thetrocar 270 into thetissue 258, themesh 260 expands toward the expanded state or its expanded quiescent shape. Tissue ingrowth secures themesh 260 to thetissue 258 to anchor the location of thedistal end 114 of theelectrode lead 104. - When the
mesh 260 comprises thewings wings FIG. 29 . In one embodiment, themesh wings connection point 268 away from thedistal end 114 of theelectrode lead 104. Upon deployment of thedistal end 114 of theelectrode lead 104 in the desiredtissue 258 of the patient, themesh sections tissue 258, as shown inFIG. 28 . Ingrowth of thetissue 258 into themesh 260 operates to anchor themesh 260 to thetissue 258, thereby anchoring thedistal end 114 of theelectrode lead 104 in the desired position. - In one embodiment, the
mesh 260 is deployed in thetissue 258 such that it has a desired orientation relative to the structure 259 of the patient. As a result, the expansion of themesh 260 can be directed to a side of theelectrode lead 104 such that it expands away from the structure 259 or toward the structure 259. For instance, when the structure 259 is in the form of the urethra of the patient, thedistal end 114 of theelectrode lead 104 can be oriented relative to the urethra 259 such that themesh 260 is located on a side of theelectrode lead 104 that is away from the urethra 259. This prevents fibrosis around themesh 260 from interfering with the communication of electrical stimulation signals from theelectrode lead 104 to the structure 259. - In one embodiment, the
anchor 257 is initially provided in a sterilized and sealed package, in which themesh 260, such asmesh sections FIG. 30 .FIG. 31 is a simplified side view of aninstallation tool 276 in accordance with embodiments of the invention that is used to prepare theanchor 257 for installation within atrocar 270. Thetool 276 comprises a forkedend 278 that includesprongs longitudinal axis 284 of thetool 276. Agap 286 between theprongs mesh 260, as illustrated in the simplified cross-sectional view ofFIG. 32 . - The
anchor 257 is prepared for installation within atrocar 270 by placing the end 288 of themesh 260 through thegap 286 and rotating thetool 276, such as in the direction indicated byarrow 290, to roll up themesh 260, as illustrated in simplified front cross-sectional views ofFIGS. 32 and 33 . Once themesh 260 has been rolled up into a compact state, thedistal end 114 of theelectrode lead 104 and theanchor 257 can be installed in atrocar 270, as illustrated in the simplified cross-sectional view ofFIG. 34 . Theend 278 of thetool 276 is disengaged from themesh 260 either prior to or after the insertion of thedistal end 114 within thetrocar 270. When thedistal end 114 of theelectrode lead 104 is deployed into the desiredtissue 258 of the patient using thetrocar 270, themesh 260 expands toward its expanded quiescent shape within thetissue 258, as discussed above. -
FIGS. 35 and 36 respectively are front and side cross-sectional views of adistal end 114 of theelectrode lead 104 comprising theanchor 257 installed within atrocar 270, in accordance with embodiments of the invention. Atool 292 is installed in thetrocar 270 to aid in the deployment of themesh wings - In one embodiment, the
tool 292 operates to separate themesh wings trocar 270. - In one embodiment, the
tool 292 is configured to cause or assist in the expansion of themesh wings tissue 258 after deployment of thedistal end 114 into thetissue 258. In one embodiment, once thedistal end 114 of theelectrode lead 104 held in thetrocar 270 is located at the desired position within thetissue 258 of the patient, thetrocar 270 is partially retracted, as illustrated in the side cross-sectional view ofFIG. 37 . In one embodiment, the cross-sectional width of theend 284 of thetool 292 is expanded, which drives themesh wings tissue 258, as illustrated inFIG. 38 . Thedistal end 294 of thetool 292 can then be withdrawn into thetrocar 270 and removed from the patient through thetrocar 270 to complete the implantation of thedistal end 114 of theelectrode lead 104 within thetissue 258 of the patient, as illustrated in the cross-sectional view ofFIG. 39 . In one embodiment, the cross-sectional width of theend 294 of thetool 292 is reduced prior to its withdrawal from the patient. - In one embodiment, the
tool 292 comprises a scissor-like mechanism that expands the effective width of thedistal end 294. -
FIGS. 40-42 are simplified side views of atool 292 in accordance with embodiments of the invention. In one embodiment, thetool 292 comprises first and secondelongated components 296 and 298 that are respectively coupled to athird component 300 throughhinges initial width 306 of thetool 292 allows thetool 292 to be received within thetrocar 270, as shown inFIGS. 35 and 36 . Following the retraction of the trocar 270 (FIG. 37 ),component 296 is moved relative to component 298, such as, for example, in the direction indicated byarrow 308. The displacement of thehinge 304 from thehinge 302 in the widthwise direction causes thecomponent 300 to pivot about thehinge 302 relative to the component 298 in the direction indicated byarrow 310 to an expanded position, as shown inFIG. 41 . Thewidth 312 of thedistal end 294 of thetool 292 in the expanded position is significantly greater than thewidth 306. This expansion of the width of thedistal end 294 drives the expansion of themesh wings FIG. 38 . - After the
mesh wings distal end 294 of thetool 292, thecomponent 296 can be further moved relative to the component 298 in a direction indicated byarrow 308 to place thedistal end 294 in a compacted state (FIG. 42 ), in which thetool 292 may either be received again within thetrocar 270, or otherwise removed from the patient, while leaving thedistal end 114 of theelectrode lead 104 in the desired location within thetissue 258 of the patient. - Additional embodiments of the invention are directed to kits that include one or more of the embodiments described above.
FIG. 43 illustrates akit 320 in accordance with embodiments of the invention. In one embodiment, the kit includes apackage 322 containing components including one or more electrode leads 104 in accordance with one or more of the embodiments described above. In one embodiment, thekit 320 includes thecontrol unit 102. In one embodiment, the kit includesinstructions 326 for installing the one or more electrode leads 104 in the patient. In one embodiment, theinstructions 324 include instructions for installing thecontrol unit 102. - In one embodiment, the one or more electrode leads 104 in the
kit 320 include ananchor 326 in accordance with one or more of the embodiments described above, such asanchor distal end 114 of the one or more electrode leads are provided pre-installed in atrocar 270. In accordance with one embodiment, one or more tools, such asinstallation tool 278 ordeployment tool 292, are provided in thekit 320. Embodiments of theinstructions 324 include instructions for implanting thedistal end 114 of theelectrode lead 104 withintissue 258 of the patient using thetrocar 270,tool 278 and/ortool 292. Such instructions include instructions describing one or more of the method steps discussed above with reference toFIGS. 32-42 . - Although the present invention has been described with reference to preferred embodiments, workers skilled in the art will recognize that changes may be made in form and detail without departing from the spirit and scope of the invention.
Claims (20)
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/558,143 US20100049289A1 (en) | 2007-07-10 | 2009-09-11 | Tissue anchor |
AU2010226813A AU2010226813B2 (en) | 2009-03-17 | 2010-03-16 | Implantable device and tissue anchor |
EP10710501.7A EP2408515B1 (en) | 2009-03-17 | 2010-03-16 | Implantable device and tissue anchor |
EP15176464.4A EP2974769B1 (en) | 2009-03-17 | 2010-03-16 | Implantable device and tissue anchor |
US13/256,825 US20120095478A1 (en) | 2009-03-17 | 2010-03-16 | Implantable device and tissue anchor |
PCT/US2010/027419 WO2010107751A2 (en) | 2009-03-17 | 2010-03-16 | Implantable device and tissue anchor |
EP10176162A EP2295109A3 (en) | 2009-09-11 | 2010-09-10 | Tissue anchor |
US13/167,541 US9427573B2 (en) | 2007-07-10 | 2011-06-23 | Deployable electrode lead anchor |
US13/431,594 US8774942B2 (en) | 2007-07-10 | 2012-03-27 | Tissue anchor |
US15/219,521 US9889292B2 (en) | 2007-07-10 | 2016-07-26 | Deployable electrode lead anchor |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94890807P | 2007-07-10 | 2007-07-10 | |
US12/170,582 US20090012592A1 (en) | 2006-07-10 | 2008-07-10 | Tissue anchor |
US9638708P | 2008-09-12 | 2008-09-12 | |
US16076509P | 2009-03-17 | 2009-03-17 | |
US12/558,143 US20100049289A1 (en) | 2007-07-10 | 2009-09-11 | Tissue anchor |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/170,582 Continuation-In-Part US20090012592A1 (en) | 2006-07-10 | 2008-07-10 | Tissue anchor |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/167,541 Continuation-In-Part US9427573B2 (en) | 2007-07-10 | 2011-06-23 | Deployable electrode lead anchor |
US13/431,594 Continuation US8774942B2 (en) | 2007-07-10 | 2012-03-27 | Tissue anchor |
Publications (1)
Publication Number | Publication Date |
---|---|
US20100049289A1 true US20100049289A1 (en) | 2010-02-25 |
Family
ID=42173301
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/558,143 Abandoned US20100049289A1 (en) | 2007-07-10 | 2009-09-11 | Tissue anchor |
US13/256,825 Abandoned US20120095478A1 (en) | 2009-03-17 | 2010-03-16 | Implantable device and tissue anchor |
US13/431,594 Active US8774942B2 (en) | 2007-07-10 | 2012-03-27 | Tissue anchor |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/256,825 Abandoned US20120095478A1 (en) | 2009-03-17 | 2010-03-16 | Implantable device and tissue anchor |
US13/431,594 Active US8774942B2 (en) | 2007-07-10 | 2012-03-27 | Tissue anchor |
Country Status (4)
Country | Link |
---|---|
US (3) | US20100049289A1 (en) |
EP (2) | EP2408515B1 (en) |
AU (1) | AU2010226813B2 (en) |
WO (1) | WO2010107751A2 (en) |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070219606A1 (en) * | 2006-03-14 | 2007-09-20 | Boston Scientific Scimed, Inc. | Heatable sling support for an anatomical location |
US20070265675A1 (en) * | 2006-05-09 | 2007-11-15 | Ams Research Corporation | Testing Efficacy of Therapeutic Mechanical or Electrical Nerve or Muscle Stimulation |
US20090036946A1 (en) * | 2001-11-29 | 2009-02-05 | American Medical Systems, Inc. | Pelvic disorder treatments |
US20090043356A1 (en) * | 2006-03-03 | 2009-02-12 | Ams Research Corporation | Electrode Sling for Treating Stress and Urge Incontinence |
US8160710B2 (en) | 2006-07-10 | 2012-04-17 | Ams Research Corporation | Systems and methods for implanting tissue stimulation electrodes in the pelvic region |
US8311647B2 (en) | 2007-01-30 | 2012-11-13 | Cardiac Pacemakers, Inc. | Direct delivery system for transvascular lead |
US8380312B2 (en) | 2009-12-31 | 2013-02-19 | Ams Research Corporation | Multi-zone stimulation implant system and method |
US8412350B2 (en) | 2007-01-30 | 2013-04-02 | Cardiac Pacemakers, Inc. | Neurostimulating lead having a stent-like anchor |
WO2013036399A3 (en) * | 2011-09-08 | 2013-06-27 | Ams Research Corporation | Implantable electrode assembly |
US8774942B2 (en) | 2007-07-10 | 2014-07-08 | Ams Research Corporation | Tissue anchor |
WO2014146000A3 (en) * | 2013-03-15 | 2014-11-06 | Micro Interventional Devices, Inc. | Tissue closure device and method |
US9050065B2 (en) | 2010-01-20 | 2015-06-09 | Micro Interventional Devices, Inc. | Tissue repair implant and delivery device and method |
US9220887B2 (en) | 2011-06-09 | 2015-12-29 | Astora Women's Health LLC | Electrode lead including a deployable tissue anchor |
US9427573B2 (en) | 2007-07-10 | 2016-08-30 | Astora Women's Health, Llc | Deployable electrode lead anchor |
WO2016168485A1 (en) | 2015-04-17 | 2016-10-20 | David Robinson | An implantable neuro-stimulation device |
US9539433B1 (en) | 2009-03-18 | 2017-01-10 | Astora Women's Health, Llc | Electrode implantation in a pelvic floor muscular structure |
CN106693173A (en) * | 2015-11-12 | 2017-05-24 | 青风医疗有限公司 | Inhibition of implant migration |
US9980708B2 (en) | 2010-01-20 | 2018-05-29 | Micro Interventional Devices, Inc. | Tissue closure device and method |
US10058314B2 (en) | 2010-01-20 | 2018-08-28 | Micro Interventional Devices, Inc. | Tissue closure device and method |
US20190060642A1 (en) * | 2015-10-15 | 2019-02-28 | Spr Therapeutics, Inc. | Apparatus and method for positioning, implanting and using a stimulation lead |
US10743854B2 (en) | 2010-01-20 | 2020-08-18 | Micro Interventional Devices, Inc. | Tissue closure device and method |
US10959840B2 (en) | 2010-01-20 | 2021-03-30 | Micro Interventional Devices, Inc. | Systems and methods for affixing a prosthesis to tissue |
US11278719B2 (en) | 2012-12-06 | 2022-03-22 | Bluewind Medical Ltd. | Delivery of implantable neurostimulators |
US11400299B1 (en) | 2021-09-14 | 2022-08-02 | Rainbow Medical Ltd. | Flexible antenna for stimulator |
US11439833B2 (en) | 2016-11-23 | 2022-09-13 | Bluewind Medical Ltd. | Implant-delivery tool |
US11612747B2 (en) | 2015-11-09 | 2023-03-28 | Bluewind Medical Ltd. | Optimization of application of current |
US11648410B2 (en) | 2012-01-26 | 2023-05-16 | Bluewind Medical Ltd. | Wireless neurostimulators |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9020597B2 (en) | 2008-11-12 | 2015-04-28 | Endostim, Inc. | Device and implantation system for electrical stimulation of biological systems |
US20150224310A1 (en) | 2006-10-09 | 2015-08-13 | Endostim, Inc. | Device and Implantation System for Electrical Stimulation of Biological Systems |
US11577077B2 (en) | 2006-10-09 | 2023-02-14 | Endostim, Inc. | Systems and methods for electrical stimulation of biological systems |
US9345879B2 (en) | 2006-10-09 | 2016-05-24 | Endostim, Inc. | Device and implantation system for electrical stimulation of biological systems |
US9724510B2 (en) | 2006-10-09 | 2017-08-08 | Endostim, Inc. | System and methods for electrical stimulation of biological systems |
US20080103572A1 (en) | 2006-10-31 | 2008-05-01 | Medtronic, Inc. | Implantable medical lead with threaded fixation |
EP2295109A3 (en) * | 2009-09-11 | 2011-05-25 | AMS Research Corporation | Tissue anchor |
US8447403B2 (en) | 2010-03-05 | 2013-05-21 | Endostim, Inc. | Device and implantation system for electrical stimulation of biological systems |
US11717681B2 (en) | 2010-03-05 | 2023-08-08 | Endostim, Inc. | Systems and methods for treating gastroesophageal reflux disease |
CN103596515A (en) | 2011-04-14 | 2014-02-19 | 恩多斯提姆公司 | Systems and methods for treating gastroesophageal reflux disease |
JP6441679B2 (en) | 2011-12-09 | 2018-12-19 | メタベンション インコーポレイテッド | Therapeutic neuromodulation of the liver system |
AU2013305543A1 (en) | 2012-08-23 | 2015-03-19 | Endostim, Inc. | Device and implantation system for electrical stimulation of biological systems |
EP3041564A4 (en) | 2013-09-03 | 2017-03-29 | Endostim, Inc. | Methods and systems of electrode polarity switching in electrical stimulation therapy |
US9889310B2 (en) | 2014-07-23 | 2018-02-13 | Medtronic, Inc. | Suture loop with cover and strategic placement of suture points |
JP6795491B2 (en) | 2014-08-15 | 2020-12-02 | アクソニクス モジュレーション テクノロジーズ インコーポレイテッド | Implantable lead attachment structure for nerve stimulation to relieve bladder dysfunction and other symptoms |
EP3297718A1 (en) | 2015-05-20 | 2018-03-28 | Cardiac Pacemakers, Inc. | Fully integrated lead stabilizer for medical electrical leads and methods of attachment |
US9517338B1 (en) | 2016-01-19 | 2016-12-13 | Axonics Modulation Technologies, Inc. | Multichannel clip device and methods of use |
US10195423B2 (en) | 2016-01-19 | 2019-02-05 | Axonics Modulation Technologies, Inc. | Multichannel clip device and methods of use |
JP6876363B2 (en) | 2016-01-29 | 2021-05-26 | アクソニクス モジュレーション テクノロジーズ インコーポレイテッド | Methods and systems for frequency adjustment that optimize the charging of implantable neurostimulators |
US10376704B2 (en) | 2016-02-12 | 2019-08-13 | Axonics Modulation Technologies, Inc. | External pulse generator device and associated methods for trial nerve stimulation |
US10524859B2 (en) | 2016-06-07 | 2020-01-07 | Metavention, Inc. | Therapeutic tissue modulation devices and methods |
US11819683B2 (en) | 2016-11-17 | 2023-11-21 | Endostim, Inc. | Modular stimulation system for the treatment of gastrointestinal disorders |
US20180242967A1 (en) * | 2017-02-26 | 2018-08-30 | Endoevolution, Llc | Apparatus and method for minimally invasive suturing |
EP3606603A1 (en) * | 2017-04-06 | 2020-02-12 | Endostim, Inc. | Implantable surface electrodes and method of implantation |
JP2021513902A (en) | 2018-02-22 | 2021-06-03 | アクソニクス モジュレーション テクノロジーズ インコーポレイテッド | Nerve Stimulation Leads and Usage for Experimental Nerve Stimulation |
NL2022555B1 (en) * | 2019-02-11 | 2020-08-19 | Salvia Bioelectronics B V | An implantable restraint and stimulation device configured for explantation |
US11642537B2 (en) | 2019-03-11 | 2023-05-09 | Axonics, Inc. | Charging device with off-center coil |
Citations (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3628538A (en) * | 1968-09-18 | 1971-12-21 | Nat Res Dev | Apparatus for stimulating muscles controlled by the same muscles |
US3640284A (en) * | 1970-01-05 | 1972-02-08 | Philip A De Langis | Apparatus for electrotherapy of the pubococcygeus |
US3646940A (en) * | 1969-07-15 | 1972-03-07 | Univ Minnesota | Implantable electronic stimulator electrode and method |
US3650276A (en) * | 1969-03-26 | 1972-03-21 | Inst Demedicina Si Farmacie | Method and apparatus, including a flexible electrode, for the electric neurostimulation of the neurogenic bladder |
US3662758A (en) * | 1969-06-30 | 1972-05-16 | Mentor Corp | Stimulator apparatus for muscular organs with external transmitter and implantable receiver |
US3667477A (en) * | 1966-11-25 | 1972-06-06 | Canadian Patents Dev | Implantable vesical stimulator |
US3866613A (en) * | 1972-07-13 | 1975-02-18 | Devices Implants Limited | Pessary ring electrode system |
US3870051A (en) * | 1972-04-27 | 1975-03-11 | Nat Res Dev | Urinary control |
US3926178A (en) * | 1975-01-17 | 1975-12-16 | Alvin N Feldzamen | Apparatus for aiding the voluntary exercising of sphincter muscles |
US3941136A (en) * | 1973-11-21 | 1976-03-02 | Neuronyx Corporation | Method for artificially inducing urination, defecation, or sexual excitation |
US3983865A (en) * | 1975-02-05 | 1976-10-05 | Shepard Richard S | Method and apparatus for myofunctional biofeedback |
US3983881A (en) * | 1975-05-21 | 1976-10-05 | Telectronics Pty. Limited | Muscle stimulator |
US4010758A (en) * | 1975-09-03 | 1977-03-08 | Medtronic, Inc. | Bipolar body tissue electrode |
US4023574A (en) * | 1974-10-18 | 1977-05-17 | Hans Nemec | Electrostimulation method and apparatus |
US4030509A (en) * | 1975-09-30 | 1977-06-21 | Mieczyslaw Mirowski | Implantable electrodes for accomplishing ventricular defibrillation and pacing and method of electrode implantation and utilization |
US4044774A (en) * | 1976-02-23 | 1977-08-30 | Medtronic, Inc. | Percutaneously inserted spinal cord stimulation lead |
US4106511A (en) * | 1976-04-21 | 1978-08-15 | Svenska Utvecklingsaktiebolaget | Electrical stimulator in remedy of incontinence |
US4136684A (en) * | 1977-02-07 | 1979-01-30 | Scattergood Mark G | Linear electromyographic biofeedback system |
US4139006A (en) * | 1977-03-18 | 1979-02-13 | Corey Arthur E | Female incontinence device |
US4153059A (en) * | 1977-10-25 | 1979-05-08 | Minnesota Mining And Manufacturing Company | Urinary incontinence stimulator system |
US4157087A (en) * | 1978-03-06 | 1979-06-05 | Med General, Inc. | Peripheral nerve stimulator |
US4165750A (en) * | 1978-03-18 | 1979-08-28 | Aleev Leonid S | Bioelectrically controlled electric stimulator of human muscles |
US4177819A (en) * | 1978-03-30 | 1979-12-11 | Kofsky Harvey I | Muscle stimulating apparatus |
US4222377A (en) * | 1977-06-27 | 1980-09-16 | American Medical Systems, Inc. | Pressure regulated artificial sphincter systems |
US4290420A (en) * | 1980-06-09 | 1981-09-22 | Alberto Manetta | Stress incontinence diagnostic and treatment device |
US4387719A (en) * | 1980-10-23 | 1983-06-14 | Gorenje Tovarna Gospodinjske Opreme N.Sol.O. Velenje | Control circuit of a therapeutic stimulator for the urinary incontinence |
US4402328A (en) * | 1981-04-28 | 1983-09-06 | Telectronics Pty. Limited | Crista terminalis atrial electrode lead |
US4406288A (en) * | 1981-04-06 | 1983-09-27 | Hugh P. Cash | Bladder control device and method |
US4414986A (en) * | 1982-01-29 | 1983-11-15 | Medtronic, Inc. | Biomedical stimulation lead |
US4431001A (en) * | 1980-09-17 | 1984-02-14 | Crafon Medical Ab | Stimulator system |
US4457299A (en) * | 1981-02-06 | 1984-07-03 | Cornwell George H I | Incontinence control devices |
US4492233A (en) * | 1982-09-14 | 1985-01-08 | Wright State University | Method and apparatus for providing feedback-controlled muscle stimulation |
US4515167A (en) * | 1983-02-28 | 1985-05-07 | Hochman Joel S | Device for the development, training and rehabilitation of the pubococcygeal and related perineal musculature of the female |
US4542753A (en) * | 1982-12-22 | 1985-09-24 | Biosonics, Inc. | Apparatus and method for stimulating penile erectile tissue |
US4568339A (en) * | 1982-11-05 | 1986-02-04 | Craig Medical Products, Limited | Female incontinence device |
US4569351A (en) * | 1984-12-20 | 1986-02-11 | University Of Health Sciences/The Chicago Medical School | Apparatus and method for stimulating micturition and certain muscles in paraplegic mammals |
US4571749A (en) * | 1982-09-21 | 1986-02-25 | The Johns Hopkins University | Manually actuated hydraulic sphincter |
US4580578A (en) * | 1983-05-06 | 1986-04-08 | Richard Wolf Gmbh | Device for the treatment of female urinary incontinence |
US4585005A (en) * | 1984-04-06 | 1986-04-29 | Regents Of University Of California | Method and pacemaker for stimulating penile erection |
US4602624A (en) * | 1984-10-11 | 1986-07-29 | Case Western Reserve University | Implantable cuff, method of manufacture, and method of installation |
US4607639A (en) * | 1984-05-18 | 1986-08-26 | Regents Of The University Of California | Method and system for controlling bladder evacuation |
US4628942A (en) * | 1984-10-11 | 1986-12-16 | Case Western Reserve University | Asymmetric shielded two electrode cuff |
US4688575A (en) * | 1982-03-12 | 1987-08-25 | Duvall Wilbur E | Muscle contraction stimulation |
US4703755A (en) * | 1984-05-18 | 1987-11-03 | The Regents Of The University Of California | Control system for the stimulation of two bodily functions |
US4731083A (en) * | 1982-09-21 | 1988-03-15 | The Johns Hopkins University | Manually actuated hydraulic sphincter |
US4739764A (en) * | 1984-05-18 | 1988-04-26 | The Regents Of The University Of California | Method for stimulating pelvic floor muscles for regulating pelvic viscera |
US4750494A (en) * | 1981-05-12 | 1988-06-14 | Medtronic, Inc. | Automatic implantable fibrillation preventer |
US4771779A (en) * | 1984-05-18 | 1988-09-20 | The Regents Of The University Of California | System for controlling bladder evacuation |
US4785828A (en) * | 1986-10-06 | 1988-11-22 | Empi, Inc. | Vaginal stimulator for controlling urinary incontinence in women |
US4848005A (en) * | 1987-02-03 | 1989-07-18 | D.E.A. Digital Electronic Automation S.P.A. | Rearrangeable supporting and positioning fixture, particularly for parts measurable on a gauging machine |
US4881526A (en) * | 1988-05-27 | 1989-11-21 | Empi, Inc. | Intravaginal electrode and stimulation system for controlling female urinary incontinence |
US4913164A (en) * | 1988-09-27 | 1990-04-03 | Intermedics, Inc. | Extensible passive fixation mechanism for lead assembly of an implantable cardiac stimulator |
US4941874A (en) * | 1987-08-11 | 1990-07-17 | Hoechst Aktiengesellschaft | Device for the administration of implants |
US5013292A (en) * | 1989-02-24 | 1991-05-07 | R. Laborie Medical Corporation | Surgical correction of female urinary stress incontinence and kit therefor |
US5019032A (en) * | 1990-04-03 | 1991-05-28 | Robertson Jack R | Refined suspension procedure with implement for treating female stress incontinence |
US5082006A (en) * | 1987-09-15 | 1992-01-21 | Linda Jonasson | Device for preventing involuntary micturition |
US5094242A (en) * | 1988-11-07 | 1992-03-10 | Regents Of The University Of California | Implantable nerve stimulation device |
US5103835A (en) * | 1990-05-02 | 1992-04-14 | Nihon Kohden Corporation | Impedance monitoring device for preventing urinary incontinence |
US5112344A (en) * | 1988-10-04 | 1992-05-12 | Petros Peter E | Surgical instrument and method of utilization of such |
US5193540A (en) * | 1991-12-18 | 1993-03-16 | Alfred E. Mann Foundation For Scientific Research | Structure and method of manufacture of an implantable microstimulator |
US5193539A (en) * | 1991-12-18 | 1993-03-16 | Alfred E. Mann Foundation For Scientific Research | Implantable microstimulator |
US5199430A (en) * | 1991-03-11 | 1993-04-06 | Case Western Reserve University | Micturitional assist device |
US5285781A (en) * | 1990-05-26 | 1994-02-15 | Stiwell S. A. | Electrical neuromuscular stimulation device |
US5291902A (en) * | 1993-01-11 | 1994-03-08 | Brent Carman | Incontinence treatment |
US5312439A (en) * | 1991-12-12 | 1994-05-17 | Loeb Gerald E | Implantable device having an electrolytic storage electrode |
US5324324A (en) * | 1992-10-13 | 1994-06-28 | Siemens Pacesetter, Inc. | Coated implantable stimulation electrode and lead |
US5330507A (en) * | 1992-04-24 | 1994-07-19 | Medtronic, Inc. | Implantable electrical vagal stimulation for prevention or interruption of life threatening arrhythmias |
US5358514A (en) * | 1991-12-18 | 1994-10-25 | Alfred E. Mann Foundation For Scientific Research | Implantable microdevice with self-attaching electrodes |
US5417226A (en) * | 1994-06-09 | 1995-05-23 | Juma; Saad | Female anti-incontinence device |
US5423329A (en) * | 1994-04-15 | 1995-06-13 | Rehab Centers Of America, Inc. | Method of treatment for urinary incontinence |
US5452719A (en) * | 1991-07-23 | 1995-09-26 | Eisman; Eugene | Multiple electrode myographic probe and method |
US5931864A (en) * | 1998-02-20 | 1999-08-03 | Cardiac Pacemakers, Inc. | Coronary venous lead having fixation mechanism |
US5954761A (en) * | 1997-03-25 | 1999-09-21 | Intermedics Inc. | Implantable endocardial lead assembly having a stent |
US6141594A (en) * | 1998-07-22 | 2000-10-31 | Cardiac Pacemakers, Inc. | Single pass lead and system with active and passive fixation elements |
US6161029A (en) * | 1999-03-08 | 2000-12-12 | Medtronic, Inc. | Apparatus and method for fixing electrodes in a blood vessel |
US6243607B1 (en) * | 1996-09-05 | 2001-06-05 | University Technologies International Inc. | Gastro-intestinal electrical pacemaker |
US6397109B1 (en) * | 1998-12-23 | 2002-05-28 | Avio Maria Perna | Single pass multiple chamber implantable electro-catheter for multi-site electrical therapy of up to four cardiac chambers, indicated in the treatment of such pathologies as atrial fibrillation and congestive/dilate cardio myopathy |
US20030019961A1 (en) * | 2001-07-20 | 2003-01-30 | Horst Hohnen | Method and device for the in situ disposal of incontinence articles |
US20030023296A1 (en) * | 2001-07-25 | 2003-01-30 | Osypka Thomas P. | Implantable coronary sinus lead with mapping capabilities |
US20030060868A1 (en) * | 1997-12-24 | 2003-03-27 | Cardiac Pacemakers, Inc. | High impedance electrode tip |
US6582441B1 (en) * | 2000-02-24 | 2003-06-24 | Advanced Bionics Corporation | Surgical insertion tool |
US6612977B2 (en) * | 2001-01-23 | 2003-09-02 | American Medical Systems Inc. | Sling delivery system and method of use |
US6911003B2 (en) * | 2002-03-07 | 2005-06-28 | Ams Research Corporation | Transobturator surgical articles and methods |
US20050149156A1 (en) * | 2003-12-24 | 2005-07-07 | Imad Libbus | Lead for stimulating the baroreceptors in the pulmonary artery |
US20050228346A1 (en) * | 2004-04-09 | 2005-10-13 | Cook Vascular Incorporated | Modular hemostatic valve |
US20060241733A1 (en) * | 2005-04-25 | 2006-10-26 | Cardiac Pacemakers, Inc. | Atrial pacing lead |
US20070043416A1 (en) * | 2005-08-19 | 2007-02-22 | Cardiac Pacemakers, Inc. | Implantable electrode array |
US20070179559A1 (en) * | 2006-01-31 | 2007-08-02 | Medtronic, Inc. | Electrical stimulation to alleviate chronic pelvic pain |
US20070255333A1 (en) * | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Neuromodulation therapy for perineal or dorsal branch of pudendal nerve |
US20070253998A1 (en) * | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Drug delivery to iliohypogastric nerve to alleviate chronic pelvic pain |
US20070255341A1 (en) * | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Electrical stimulation of ilioinguinal nerve to alleviate chronic pelvic pain |
US20070253997A1 (en) * | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Drug delivery to alleviate chronic pelvic pain |
US7319905B1 (en) * | 2004-11-30 | 2008-01-15 | Pacesetter, Inc. | Passive fixation mechanism for epicardial sensing and stimulation lead placed through pericardial access |
US7613516B2 (en) * | 2001-11-29 | 2009-11-03 | Ams Research Corporation | Pelvic disorder treatment device |
US7771345B1 (en) * | 2002-12-03 | 2010-08-10 | O'donnell Pat D | Surgical instrument for treating female urinary stress incontinence |
Family Cites Families (139)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3999555A (en) | 1975-10-28 | 1976-12-28 | Medtronic, Inc. | Atrial pinch on lead and insertion tool |
US4419819A (en) * | 1982-01-29 | 1983-12-13 | Medtronic, Inc. | Method of making biomedical lead with lobed lead anchor |
US4669488A (en) * | 1983-03-28 | 1987-06-02 | Cordis Corporation | Retention skirt for pacing electrode assembly |
US4519404A (en) * | 1983-09-28 | 1985-05-28 | Fleischhacker John J | Endocardial electrode lead with conical fixation mechanism |
US4550737A (en) | 1983-10-12 | 1985-11-05 | Peter Osypka | Intravenously implantable electrode lead for use with cardiac pacemakers |
EP0245547B1 (en) | 1986-05-12 | 1990-08-22 | The Regents Of The University Of California | Electronic control system for controlling pelvic viscera via neuro-electrical stimulation |
US4590949A (en) | 1984-11-01 | 1986-05-27 | Cordis Corporation | Neural stimulating lead with stabilizing mechanism and method for using same |
US5520606A (en) | 1990-10-18 | 1996-05-28 | Schoolman; Arnold | Mechanical urinary sphincter device |
US6131575A (en) | 1991-01-10 | 2000-10-17 | The Procter & Gamble Company | Urinary incontinence device |
US5439467A (en) | 1991-12-03 | 1995-08-08 | Vesica Medical, Inc. | Suture passer |
CA2181674A1 (en) | 1991-12-03 | 1993-10-04 | Theodore V. Benderev | Support structure for supporting and positioning medical equipment |
US5324327A (en) * | 1991-12-17 | 1994-06-28 | Cohen Donald M | Low threshold cardiac pacing lead |
GB9211085D0 (en) | 1992-05-23 | 1992-07-08 | Tippey Keith E | Electrical stimulation |
US5344439A (en) | 1992-10-30 | 1994-09-06 | Medtronic, Inc. | Catheter with retractable anchor mechanism |
US5484445A (en) | 1993-10-12 | 1996-01-16 | Medtronic, Inc. | Sacral lead anchoring system |
US5400784A (en) | 1993-10-15 | 1995-03-28 | Case Western Reserve University | Slowly penetrating inter-fascicular nerve cuff electrode and method of using |
US5370670A (en) | 1993-12-13 | 1994-12-06 | Thomas Jefferson University | Detrusor myoplasty and neuromuscular electrical stimulation of the urinary bladder |
US5518504A (en) | 1993-12-28 | 1996-05-21 | American Medical Systems, Inc. | Implantable sphincter system utilizing lifting means |
US5603685A (en) | 1994-07-01 | 1997-02-18 | Tutrone, Jr.; Donald F. | Inflatable vaginal pessary |
US5571148A (en) | 1994-08-10 | 1996-11-05 | Loeb; Gerald E. | Implantable multichannel stimulator |
SE506164C2 (en) | 1995-10-09 | 1997-11-17 | Medscand Medical Ab | Instruments for the treatment of urinary incontinence in women |
US5899909A (en) | 1994-08-30 | 1999-05-04 | Medscand Medical Ab | Surgical instrument for treating female urinary incontinence |
US5833595A (en) | 1994-09-06 | 1998-11-10 | Lin; Vernon Wen-Hau | Treatment of excretory problems |
US5569351A (en) | 1994-11-14 | 1996-10-29 | Cms Gilbreth Packaging Systems, Inc. | Banding machine having improved film registration system |
US5591217A (en) | 1995-01-04 | 1997-01-07 | Plexus, Inc. | Implantable stimulator with replenishable, high value capacitive power source and method therefor |
AU1057697A (en) | 1995-11-24 | 1997-06-11 | Advanced Bionics Corporation | System and method for conditioning pelvic musculature using an implanted microstimulator |
GB9601383D0 (en) | 1996-01-24 | 1996-03-27 | Lenadora Shantha J B | Device for genuine stress incontinence in the female |
EP0788813B1 (en) | 1996-02-15 | 2003-10-15 | Nihon Kohden Corporation | An apparatus for treating urinary incontinence |
US6051017A (en) | 1996-02-20 | 2000-04-18 | Advanced Bionics Corporation | Implantable microstimulator and systems employing the same |
US6006134A (en) | 1998-04-30 | 1999-12-21 | Medtronic, Inc. | Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers |
US6132384A (en) * | 1996-06-26 | 2000-10-17 | Medtronic, Inc. | Sensor, method of sensor implant and system for treatment of respiratory disorders |
US5957920A (en) | 1997-08-28 | 1999-09-28 | Isothermix, Inc. | Medical instruments and techniques for treatment of urinary incontinence |
US5755767A (en) * | 1996-08-02 | 1998-05-26 | Pacesetter, Inc. | Anti-dislodgment and anti-perforation distal tip design for transvenous lead |
ATE339917T1 (en) | 1996-10-23 | 2006-10-15 | Oratec Interventions Inc | DEVICE FOR TREATING INTERVERBEL DISCS |
DK0846474T3 (en) | 1996-10-30 | 2003-09-22 | Nihon Kohden Corp | Urinary incontinence prevention device |
US6026326A (en) | 1997-01-13 | 2000-02-15 | Medtronic, Inc. | Apparatus and method for treating chronic constipation |
US6042534A (en) | 1997-02-13 | 2000-03-28 | Scimed Life Systems, Inc. | Stabilization sling for use in minimally invasive pelvic surgery |
US6208894B1 (en) | 1997-02-26 | 2001-03-27 | Alfred E. Mann Foundation For Scientific Research And Advanced Bionics | System of implantable devices for monitoring and/or affecting body parameters |
EP1666087A3 (en) | 1997-02-26 | 2009-04-29 | The Alfred E Mann Foundation for Scientific Research | Battery-powered patient implantable device |
US5957965A (en) | 1997-03-03 | 1999-09-28 | Medtronic, Inc. | Sacral medical electrical lead |
US6039686A (en) | 1997-03-18 | 2000-03-21 | Kovac; S. Robert | System and a method for the long term cure of recurrent urinary female incontinence |
US6135945A (en) | 1997-08-04 | 2000-10-24 | Sultan; Hashem | Anti-incontinence device |
US5824027A (en) | 1997-08-14 | 1998-10-20 | Simon Fraser University | Nerve cuff having one or more isolated chambers |
US7628795B2 (en) | 1997-09-24 | 2009-12-08 | Atrium Medical Corporation | Tunneling device for use with a graft |
US6149636A (en) | 1998-06-29 | 2000-11-21 | The Procter & Gamble Company | Disposable article having proactive sensors |
US6104955A (en) | 1997-12-15 | 2000-08-15 | Medtronic, Inc. | Method and apparatus for electrical stimulation of the gastrointestinal tract |
US6212434B1 (en) | 1998-07-22 | 2001-04-03 | Cardiac Pacemakers, Inc. | Single pass lead system |
US6321116B1 (en) | 1998-02-08 | 2001-11-20 | Seung Kee Mo | Electrical apparatus medical treatment using EMG envelope signal |
US6382214B1 (en) | 1998-04-24 | 2002-05-07 | American Medical Systems, Inc. | Methods and apparatus for correction of urinary and gynecological pathologies including treatment of male incontinence and female cystocele |
US6161047A (en) | 1998-04-30 | 2000-12-12 | Medtronic Inc. | Apparatus and method for expanding a stimulation lead body in situ |
JP4407868B2 (en) | 1998-06-29 | 2010-02-03 | ザ プロクター アンド ギャンブル カンパニー | Disposable product with forward sensor |
US6941171B2 (en) | 1998-07-06 | 2005-09-06 | Advanced Bionics Corporation | Implantable stimulator methods for treatment of incontinence and pain |
US6735474B1 (en) | 1998-07-06 | 2004-05-11 | Advanced Bionics Corporation | Implantable stimulator system and method for treatment of incontinence and pain |
US6027456A (en) | 1998-07-10 | 2000-02-22 | Advanced Neuromodulation Systems, Inc. | Apparatus and method for positioning spinal cord stimulation leads |
US6104960A (en) | 1998-07-13 | 2000-08-15 | Medtronic, Inc. | System and method for providing medical electrical stimulation to a portion of the nervous system |
US6002964A (en) | 1998-07-15 | 1999-12-14 | Feler; Claudio A. | Epidural nerve root stimulation |
US6042536A (en) | 1998-08-13 | 2000-03-28 | Contimed, Inc. | Bladder sling |
US6240316B1 (en) | 1998-08-14 | 2001-05-29 | Advanced Bionics Corporation | Implantable microstimulation system for treatment of sleep apnea |
AU6118699A (en) | 1998-10-06 | 2000-04-26 | Bio Control Medical, Ltd. | Control of urge incontinence |
IL127481A (en) | 1998-10-06 | 2004-05-12 | Bio Control Medical Ltd | Incontinence treatment device |
US6505074B2 (en) | 1998-10-26 | 2003-01-07 | Birinder R. Boveja | Method and apparatus for electrical stimulation adjunct (add-on) treatment of urinary incontinence and urological disorders using an external stimulator |
US6366814B1 (en) | 1998-10-26 | 2002-04-02 | Birinder R. Boveja | External stimulator for adjunct (add-on) treatment for neurological, neuropsychiatric, and urological disorders |
US6356788B2 (en) | 1998-10-26 | 2002-03-12 | Birinder Bob Boveja | Apparatus and method for adjunct (add-on) therapy for depression, migraine, neuropsychiatric disorders, partial complex epilepsy, generalized epilepsy and involuntary movement disorders utilizing an external stimulator |
US6964643B2 (en) | 1998-11-18 | 2005-11-15 | Nugyn, Inc. | Devices and methods for treatment of incontinence |
US6304786B1 (en) | 1999-03-29 | 2001-10-16 | Cardiac Pacemakers, Inc. | Implantable lead with dissolvable coating for improved fixation and extraction |
US20010025192A1 (en) | 1999-04-29 | 2001-09-27 | Medtronic, Inc. | Single and multi-polar implantable lead for sacral nerve electrical stimulation |
US6055456A (en) | 1999-04-29 | 2000-04-25 | Medtronic, Inc. | Single and multi-polar implantable lead for sacral nerve electrical stimulation |
US6341236B1 (en) | 1999-04-30 | 2002-01-22 | Ivan Osorio | Vagal nerve stimulation techniques for treatment of epileptic seizures |
AUPQ202699A0 (en) | 1999-08-04 | 1999-08-26 | University Of Melbourne, The | Prosthetic device for incontinence |
US20030028232A1 (en) | 2000-01-20 | 2003-02-06 | Medtronic, Inc. | Method of lmplanting a medical electrical lead |
GB2359256B (en) | 2000-01-21 | 2004-03-03 | Sofradim Production | Percutaneous device for treating urinary stress incontinence in women using a sub-urethral tape |
US7079882B1 (en) | 2000-01-22 | 2006-07-18 | Richard Schmidt | Method and apparatus for quantifying nerve and neural-muscular integrity related to pelvic organs or pelvic floor functions |
US6650943B1 (en) | 2000-04-07 | 2003-11-18 | Advanced Bionics Corporation | Fully implantable neurostimulator for cavernous nerve stimulation as a therapy for erectile dysfunction and other sexual dysfunction |
JP4783490B2 (en) | 2000-04-17 | 2011-09-28 | 東レ・ダウコーニング株式会社 | Organopolysiloxane composition and method for producing the same |
EP1326675B1 (en) | 2000-09-07 | 2011-04-13 | Mann Medical Research Organization | Apparatus for control of bowel function |
US6418930B1 (en) | 2000-11-14 | 2002-07-16 | Mayo Foundation For Medical Education And Research | Anatomic incontinence pessary |
US6971393B1 (en) | 2000-11-15 | 2005-12-06 | George Mamo | Minimally invasive method for implanting a sacral stimulation lead |
JP4156364B2 (en) | 2000-11-20 | 2008-09-24 | エシコン・インコーポレイテッド | Surgical instruments and methods for treating female urinary incontinence |
US20020161382A1 (en) | 2001-03-29 | 2002-10-31 | Neisz Johann J. | Implant inserted without bone anchors |
US6652450B2 (en) | 2001-01-23 | 2003-11-25 | American Medical Systems, Inc. | Implantable article and method for treating urinary incontinence using means for repositioning the implantable article |
US7070556B2 (en) | 2002-03-07 | 2006-07-04 | Ams Research Corporation | Transobturator surgical articles and methods |
US6641525B2 (en) | 2001-01-23 | 2003-11-04 | Ams Research Corporation | Sling assembly with secure and convenient attachment |
US6952613B2 (en) | 2001-01-31 | 2005-10-04 | Medtronic, Inc. | Implantable gastrointestinal lead with active fixation |
EP1416903A2 (en) | 2001-07-20 | 2004-05-12 | Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California | Method and apparatus for the treatment of urinary tract dysfunction |
US7407480B2 (en) | 2001-07-27 | 2008-08-05 | Ams Research Corporation | Method and apparatus for correction of urinary and gynecological pathologies, including treatment of incontinence cystocele |
US6600956B2 (en) | 2001-08-21 | 2003-07-29 | Cyberonics, Inc. | Circumneural electrode assembly |
US6999819B2 (en) | 2001-08-31 | 2006-02-14 | Medtronic, Inc. | Implantable medical electrical stimulation lead fixation method and apparatus |
US6745079B2 (en) | 2001-11-07 | 2004-06-01 | Medtronic, Inc. | Electrical tissue stimulation apparatus and method |
US6862480B2 (en) | 2001-11-29 | 2005-03-01 | Biocontrol Medical Ltd. | Pelvic disorder treatment device |
US6712772B2 (en) | 2001-11-29 | 2004-03-30 | Biocontrol Medical Ltd. | Low power consumption implantable pressure sensor |
US20030199961A1 (en) | 2002-04-03 | 2003-10-23 | Bjorklund Vicki L. | Method and apparatus for fixating a pacing lead of an implantable medical device |
US7695427B2 (en) | 2002-04-26 | 2010-04-13 | Torax Medical, Inc. | Methods and apparatus for treating body tissue sphincters and the like |
US6964699B1 (en) | 2002-06-05 | 2005-11-15 | The United States Of America As Represented By The Secretary Of The Navy | Rocket motor exhaust scrubber |
US7292890B2 (en) | 2002-06-20 | 2007-11-06 | Advanced Bionics Corporation | Vagus nerve stimulation via unidirectional propagation of action potentials |
US7203548B2 (en) | 2002-06-20 | 2007-04-10 | Advanced Bionics Corporation | Cavernous nerve stimulation via unidirectional propagation of action potentials |
US7860570B2 (en) | 2002-06-20 | 2010-12-28 | Boston Scientific Neuromodulation Corporation | Implantable microstimulators and methods for unidirectional propagation of action potentials |
US20040015205A1 (en) | 2002-06-20 | 2004-01-22 | Whitehurst Todd K. | Implantable microstimulators with programmable multielectrode configuration and uses thereof |
AU2003279616A1 (en) | 2002-06-28 | 2004-01-19 | Advanced Bionics Corporation | Microstimulator having self-contained power source and bi-directional telemetry system |
US20040242956A1 (en) | 2002-07-29 | 2004-12-02 | Scorvo Sean K. | System for controlling fluid in a body |
US7328068B2 (en) | 2003-03-31 | 2008-02-05 | Medtronic, Inc. | Method, system and device for treating disorders of the pelvic floor by means of electrical stimulation of the pudendal and associated nerves, and the optional delivery of drugs in association therewith |
US20040068203A1 (en) | 2002-10-03 | 2004-04-08 | Scimed Life Systems, Inc. | Sensing pressure |
FR2847169B1 (en) | 2002-11-20 | 2005-02-18 | Vygon | DEVICE FOR LOCOREGIONAL ANESTHESIA AND METHOD FOR MANUFACTURING THE CANNULA OF THE DEVICE |
US7343206B2 (en) * | 2003-04-25 | 2008-03-11 | Medtronic, Inc. | Implantable medical lead and system, and method of use thereof |
US20040248979A1 (en) | 2003-06-03 | 2004-12-09 | Dynogen Pharmaceuticals, Inc. | Method of treating lower urinary tract disorders |
US20050038489A1 (en) | 2003-08-14 | 2005-02-17 | Grill Warren M. | Electrode array for use in medical stimulation and methods thereof |
US7303525B2 (en) | 2003-08-22 | 2007-12-04 | Ams Research Corporation | Surgical article and methods for treating female urinary incontinence |
US7343202B2 (en) | 2004-02-12 | 2008-03-11 | Ndi Medical, Llc. | Method for affecting urinary function with electrode implantation in adipose tissue |
US7347812B2 (en) | 2003-09-22 | 2008-03-25 | Ams Research Corporation | Prolapse repair |
US8751003B2 (en) | 2004-02-11 | 2014-06-10 | Ethicon, Inc. | Conductive mesh for neurostimulation |
US7120499B2 (en) | 2004-02-12 | 2006-10-10 | Ndi Medical, Llc | Portable percutaneous assemblies, systems and methods for providing highly selective functional or therapeutic neuromuscular stimulation |
US8467875B2 (en) | 2004-02-12 | 2013-06-18 | Medtronic, Inc. | Stimulation of dorsal genital nerves to treat urologic dysfunctions |
US20080132969A1 (en) | 2004-02-12 | 2008-06-05 | Ndi Medical, Inc. | Systems and methods for bilateral stimulation of left and right branches of the dorsal genital nerves to treat urologic dysfunctions |
ES2395128T3 (en) | 2004-02-12 | 2013-02-08 | Ndi Medical, Llc | Portable sets and systems to provide functional or therapeutic neuromuscular stimulation |
US8086318B2 (en) | 2004-02-12 | 2011-12-27 | Ndi Medical, Llc | Portable assemblies, systems, and methods for providing functional or therapeutic neurostimulation |
US7351197B2 (en) | 2004-05-07 | 2008-04-01 | Ams Research Corporation | Method and apparatus for cystocele repair |
US7500945B2 (en) | 2004-04-30 | 2009-03-10 | Ams Research Corporation | Method and apparatus for treating pelvic organ prolapse |
US20080071321A1 (en) | 2004-06-10 | 2008-03-20 | Ndi Medical, Inc. | Systems and methods of neuromodulation stimulation for the restoration of sexual function |
AU2005254016A1 (en) | 2004-06-10 | 2005-12-29 | Ndi Medical, Llc | Systems and methods for bilateral stimulation of left and right branches of the dorsal genital nerves to treat dysfunctions, such as urinary incontinence |
WO2006047833A1 (en) | 2004-11-08 | 2006-05-11 | Continence Control Systems International Pty Ltd | An implantable electrode arrangement |
US7930039B2 (en) * | 2005-01-07 | 2011-04-19 | Medtronic, Inc. | Implantable retention system and method |
US7914437B2 (en) | 2005-02-04 | 2011-03-29 | Ams Research Corporation | Transobturator methods for installing sling to treat incontinence, and related devices |
CA2608017C (en) | 2005-05-13 | 2014-07-29 | Ndi Medical, Llc | Systems for electrical stimulation of nerves in adipose tissue regions |
US20100010290A1 (en) * | 2005-09-02 | 2010-01-14 | Continence Control Systems International Pty Ltd. | Smooth muscle implant for managing a medical condition |
US20070100411A1 (en) | 2005-10-27 | 2007-05-03 | Medtronic, Inc. | Implantable medical electrical stimulation lead fixation method and apparatus |
WO2007097994A2 (en) | 2006-02-16 | 2007-08-30 | Ams Research Corporation | Surgical articles and methods for treating pelvic conditions |
US8195296B2 (en) | 2006-03-03 | 2012-06-05 | Ams Research Corporation | Apparatus for treating stress and urge incontinence |
US20090157091A1 (en) | 2006-04-04 | 2009-06-18 | Ams Research Corporation | Apparatus for Implanting Neural Stimulation Leads |
US20100318098A1 (en) | 2006-04-04 | 2010-12-16 | Lund Robert E | Systems and Methods for Implanting Medical Devices |
US20070265675A1 (en) | 2006-05-09 | 2007-11-15 | Ams Research Corporation | Testing Efficacy of Therapeutic Mechanical or Electrical Nerve or Muscle Stimulation |
US8052731B2 (en) | 2006-06-02 | 2011-11-08 | Cardiac Pacemakers, Inc. | Medical electrical lead with expandable fixation features |
US20100076254A1 (en) | 2006-06-05 | 2010-03-25 | Ams Research Corporation | Electrical muscle stimulation to treat fecal incontinence and/or pelvic prolapse |
US7725197B2 (en) | 2006-06-15 | 2010-05-25 | Cardiac Pacemakers, Inc. | Medical electrical lead with friction-enhancing fixation features |
US20090012592A1 (en) * | 2006-07-10 | 2009-01-08 | Ams Research Corporation | Tissue anchor |
US8160710B2 (en) | 2006-07-10 | 2012-04-17 | Ams Research Corporation | Systems and methods for implanting tissue stimulation electrodes in the pelvic region |
US7647113B2 (en) | 2006-12-21 | 2010-01-12 | Ams Research Corporation | Electrode implantation in male external urinary sphincter |
US20100049289A1 (en) | 2007-07-10 | 2010-02-25 | Ams Research Corporation | Tissue anchor |
EP2187820A2 (en) * | 2007-08-17 | 2010-05-26 | Wilson-Cook Medical Inc. | Suture lock |
US20090259280A1 (en) | 2007-10-15 | 2009-10-15 | Kevin Wilkin | Electrical stimulation lead with bioerodible anchors and anchor straps |
US8019443B2 (en) | 2008-04-01 | 2011-09-13 | Boston Scientific Neuromodulation Corporation | Anchoring units for leads of implantable electric stimulation systems and methods of making and using |
-
2009
- 2009-09-11 US US12/558,143 patent/US20100049289A1/en not_active Abandoned
-
2010
- 2010-03-16 EP EP10710501.7A patent/EP2408515B1/en not_active Not-in-force
- 2010-03-16 AU AU2010226813A patent/AU2010226813B2/en not_active Ceased
- 2010-03-16 WO PCT/US2010/027419 patent/WO2010107751A2/en active Application Filing
- 2010-03-16 US US13/256,825 patent/US20120095478A1/en not_active Abandoned
- 2010-03-16 EP EP15176464.4A patent/EP2974769B1/en not_active Not-in-force
-
2012
- 2012-03-27 US US13/431,594 patent/US8774942B2/en active Active
Patent Citations (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3667477A (en) * | 1966-11-25 | 1972-06-06 | Canadian Patents Dev | Implantable vesical stimulator |
US3628538A (en) * | 1968-09-18 | 1971-12-21 | Nat Res Dev | Apparatus for stimulating muscles controlled by the same muscles |
US3650276A (en) * | 1969-03-26 | 1972-03-21 | Inst Demedicina Si Farmacie | Method and apparatus, including a flexible electrode, for the electric neurostimulation of the neurogenic bladder |
US3662758A (en) * | 1969-06-30 | 1972-05-16 | Mentor Corp | Stimulator apparatus for muscular organs with external transmitter and implantable receiver |
US3646940A (en) * | 1969-07-15 | 1972-03-07 | Univ Minnesota | Implantable electronic stimulator electrode and method |
US3640284A (en) * | 1970-01-05 | 1972-02-08 | Philip A De Langis | Apparatus for electrotherapy of the pubococcygeus |
US3870051A (en) * | 1972-04-27 | 1975-03-11 | Nat Res Dev | Urinary control |
US3866613A (en) * | 1972-07-13 | 1975-02-18 | Devices Implants Limited | Pessary ring electrode system |
US3941136A (en) * | 1973-11-21 | 1976-03-02 | Neuronyx Corporation | Method for artificially inducing urination, defecation, or sexual excitation |
US4023574A (en) * | 1974-10-18 | 1977-05-17 | Hans Nemec | Electrostimulation method and apparatus |
US3926178A (en) * | 1975-01-17 | 1975-12-16 | Alvin N Feldzamen | Apparatus for aiding the voluntary exercising of sphincter muscles |
US3983865A (en) * | 1975-02-05 | 1976-10-05 | Shepard Richard S | Method and apparatus for myofunctional biofeedback |
US3983881A (en) * | 1975-05-21 | 1976-10-05 | Telectronics Pty. Limited | Muscle stimulator |
US4010758A (en) * | 1975-09-03 | 1977-03-08 | Medtronic, Inc. | Bipolar body tissue electrode |
US4030509A (en) * | 1975-09-30 | 1977-06-21 | Mieczyslaw Mirowski | Implantable electrodes for accomplishing ventricular defibrillation and pacing and method of electrode implantation and utilization |
US4044774A (en) * | 1976-02-23 | 1977-08-30 | Medtronic, Inc. | Percutaneously inserted spinal cord stimulation lead |
US4106511A (en) * | 1976-04-21 | 1978-08-15 | Svenska Utvecklingsaktiebolaget | Electrical stimulator in remedy of incontinence |
US4136684A (en) * | 1977-02-07 | 1979-01-30 | Scattergood Mark G | Linear electromyographic biofeedback system |
US4139006A (en) * | 1977-03-18 | 1979-02-13 | Corey Arthur E | Female incontinence device |
US4222377A (en) * | 1977-06-27 | 1980-09-16 | American Medical Systems, Inc. | Pressure regulated artificial sphincter systems |
US4153059A (en) * | 1977-10-25 | 1979-05-08 | Minnesota Mining And Manufacturing Company | Urinary incontinence stimulator system |
US4157087A (en) * | 1978-03-06 | 1979-06-05 | Med General, Inc. | Peripheral nerve stimulator |
US4165750A (en) * | 1978-03-18 | 1979-08-28 | Aleev Leonid S | Bioelectrically controlled electric stimulator of human muscles |
US4177819A (en) * | 1978-03-30 | 1979-12-11 | Kofsky Harvey I | Muscle stimulating apparatus |
US4290420A (en) * | 1980-06-09 | 1981-09-22 | Alberto Manetta | Stress incontinence diagnostic and treatment device |
US4431001A (en) * | 1980-09-17 | 1984-02-14 | Crafon Medical Ab | Stimulator system |
US4387719A (en) * | 1980-10-23 | 1983-06-14 | Gorenje Tovarna Gospodinjske Opreme N.Sol.O. Velenje | Control circuit of a therapeutic stimulator for the urinary incontinence |
US4457299A (en) * | 1981-02-06 | 1984-07-03 | Cornwell George H I | Incontinence control devices |
US4406288A (en) * | 1981-04-06 | 1983-09-27 | Hugh P. Cash | Bladder control device and method |
US4402328A (en) * | 1981-04-28 | 1983-09-06 | Telectronics Pty. Limited | Crista terminalis atrial electrode lead |
US4750494A (en) * | 1981-05-12 | 1988-06-14 | Medtronic, Inc. | Automatic implantable fibrillation preventer |
US4414986A (en) * | 1982-01-29 | 1983-11-15 | Medtronic, Inc. | Biomedical stimulation lead |
US4688575A (en) * | 1982-03-12 | 1987-08-25 | Duvall Wilbur E | Muscle contraction stimulation |
US4492233A (en) * | 1982-09-14 | 1985-01-08 | Wright State University | Method and apparatus for providing feedback-controlled muscle stimulation |
US4731083A (en) * | 1982-09-21 | 1988-03-15 | The Johns Hopkins University | Manually actuated hydraulic sphincter |
US4571749A (en) * | 1982-09-21 | 1986-02-25 | The Johns Hopkins University | Manually actuated hydraulic sphincter |
US4568339A (en) * | 1982-11-05 | 1986-02-04 | Craig Medical Products, Limited | Female incontinence device |
US4542753A (en) * | 1982-12-22 | 1985-09-24 | Biosonics, Inc. | Apparatus and method for stimulating penile erectile tissue |
US4515167A (en) * | 1983-02-28 | 1985-05-07 | Hochman Joel S | Device for the development, training and rehabilitation of the pubococcygeal and related perineal musculature of the female |
US4580578A (en) * | 1983-05-06 | 1986-04-08 | Richard Wolf Gmbh | Device for the treatment of female urinary incontinence |
US4585005A (en) * | 1984-04-06 | 1986-04-29 | Regents Of University Of California | Method and pacemaker for stimulating penile erection |
US4607639A (en) * | 1984-05-18 | 1986-08-26 | Regents Of The University Of California | Method and system for controlling bladder evacuation |
US4703755A (en) * | 1984-05-18 | 1987-11-03 | The Regents Of The University Of California | Control system for the stimulation of two bodily functions |
US4739764A (en) * | 1984-05-18 | 1988-04-26 | The Regents Of The University Of California | Method for stimulating pelvic floor muscles for regulating pelvic viscera |
US4771779A (en) * | 1984-05-18 | 1988-09-20 | The Regents Of The University Of California | System for controlling bladder evacuation |
US4628942A (en) * | 1984-10-11 | 1986-12-16 | Case Western Reserve University | Asymmetric shielded two electrode cuff |
US4602624A (en) * | 1984-10-11 | 1986-07-29 | Case Western Reserve University | Implantable cuff, method of manufacture, and method of installation |
US4569351A (en) * | 1984-12-20 | 1986-02-11 | University Of Health Sciences/The Chicago Medical School | Apparatus and method for stimulating micturition and certain muscles in paraplegic mammals |
US4785828A (en) * | 1986-10-06 | 1988-11-22 | Empi, Inc. | Vaginal stimulator for controlling urinary incontinence in women |
US4848005A (en) * | 1987-02-03 | 1989-07-18 | D.E.A. Digital Electronic Automation S.P.A. | Rearrangeable supporting and positioning fixture, particularly for parts measurable on a gauging machine |
US4941874A (en) * | 1987-08-11 | 1990-07-17 | Hoechst Aktiengesellschaft | Device for the administration of implants |
US5082006A (en) * | 1987-09-15 | 1992-01-21 | Linda Jonasson | Device for preventing involuntary micturition |
US4881526A (en) * | 1988-05-27 | 1989-11-21 | Empi, Inc. | Intravaginal electrode and stimulation system for controlling female urinary incontinence |
US4913164A (en) * | 1988-09-27 | 1990-04-03 | Intermedics, Inc. | Extensible passive fixation mechanism for lead assembly of an implantable cardiac stimulator |
US5112344A (en) * | 1988-10-04 | 1992-05-12 | Petros Peter E | Surgical instrument and method of utilization of such |
US5094242A (en) * | 1988-11-07 | 1992-03-10 | Regents Of The University Of California | Implantable nerve stimulation device |
US5013292A (en) * | 1989-02-24 | 1991-05-07 | R. Laborie Medical Corporation | Surgical correction of female urinary stress incontinence and kit therefor |
US5019032A (en) * | 1990-04-03 | 1991-05-28 | Robertson Jack R | Refined suspension procedure with implement for treating female stress incontinence |
US5103835A (en) * | 1990-05-02 | 1992-04-14 | Nihon Kohden Corporation | Impedance monitoring device for preventing urinary incontinence |
US5285781A (en) * | 1990-05-26 | 1994-02-15 | Stiwell S. A. | Electrical neuromuscular stimulation device |
US5199430A (en) * | 1991-03-11 | 1993-04-06 | Case Western Reserve University | Micturitional assist device |
US5452719A (en) * | 1991-07-23 | 1995-09-26 | Eisman; Eugene | Multiple electrode myographic probe and method |
US5312439A (en) * | 1991-12-12 | 1994-05-17 | Loeb Gerald E | Implantable device having an electrolytic storage electrode |
US5193539A (en) * | 1991-12-18 | 1993-03-16 | Alfred E. Mann Foundation For Scientific Research | Implantable microstimulator |
US5324316A (en) * | 1991-12-18 | 1994-06-28 | Alfred E. Mann Foundation For Scientific Research | Implantable microstimulator |
US5358514A (en) * | 1991-12-18 | 1994-10-25 | Alfred E. Mann Foundation For Scientific Research | Implantable microdevice with self-attaching electrodes |
US5405367A (en) * | 1991-12-18 | 1995-04-11 | Alfred E. Mann Foundation For Scientific Research | Structure and method of manufacture of an implantable microstimulator |
US5193540A (en) * | 1991-12-18 | 1993-03-16 | Alfred E. Mann Foundation For Scientific Research | Structure and method of manufacture of an implantable microstimulator |
US5330507A (en) * | 1992-04-24 | 1994-07-19 | Medtronic, Inc. | Implantable electrical vagal stimulation for prevention or interruption of life threatening arrhythmias |
US5324324A (en) * | 1992-10-13 | 1994-06-28 | Siemens Pacesetter, Inc. | Coated implantable stimulation electrode and lead |
US5291902A (en) * | 1993-01-11 | 1994-03-08 | Brent Carman | Incontinence treatment |
US5411548A (en) * | 1993-01-11 | 1995-05-02 | Carman; Brent | Method of varying appropriate muscle strength of a person to alleviate urinary or fecal urgency or incontinence or vaginal or bladder spasms |
US5423329A (en) * | 1994-04-15 | 1995-06-13 | Rehab Centers Of America, Inc. | Method of treatment for urinary incontinence |
US5417226A (en) * | 1994-06-09 | 1995-05-23 | Juma; Saad | Female anti-incontinence device |
US6243607B1 (en) * | 1996-09-05 | 2001-06-05 | University Technologies International Inc. | Gastro-intestinal electrical pacemaker |
US5954761A (en) * | 1997-03-25 | 1999-09-21 | Intermedics Inc. | Implantable endocardial lead assembly having a stent |
US20030060868A1 (en) * | 1997-12-24 | 2003-03-27 | Cardiac Pacemakers, Inc. | High impedance electrode tip |
US5931864A (en) * | 1998-02-20 | 1999-08-03 | Cardiac Pacemakers, Inc. | Coronary venous lead having fixation mechanism |
US6178356B1 (en) * | 1998-02-20 | 2001-01-23 | Cardiac Pacemakers, Inc. | Coronary venous lead having fixation mechanism |
US6141594A (en) * | 1998-07-22 | 2000-10-31 | Cardiac Pacemakers, Inc. | Single pass lead and system with active and passive fixation elements |
US6397109B1 (en) * | 1998-12-23 | 2002-05-28 | Avio Maria Perna | Single pass multiple chamber implantable electro-catheter for multi-site electrical therapy of up to four cardiac chambers, indicated in the treatment of such pathologies as atrial fibrillation and congestive/dilate cardio myopathy |
US6161029A (en) * | 1999-03-08 | 2000-12-12 | Medtronic, Inc. | Apparatus and method for fixing electrodes in a blood vessel |
US6582441B1 (en) * | 2000-02-24 | 2003-06-24 | Advanced Bionics Corporation | Surgical insertion tool |
US6612977B2 (en) * | 2001-01-23 | 2003-09-02 | American Medical Systems Inc. | Sling delivery system and method of use |
US20030019961A1 (en) * | 2001-07-20 | 2003-01-30 | Horst Hohnen | Method and device for the in situ disposal of incontinence articles |
US20030023296A1 (en) * | 2001-07-25 | 2003-01-30 | Osypka Thomas P. | Implantable coronary sinus lead with mapping capabilities |
US7613516B2 (en) * | 2001-11-29 | 2009-11-03 | Ams Research Corporation | Pelvic disorder treatment device |
US6911003B2 (en) * | 2002-03-07 | 2005-06-28 | Ams Research Corporation | Transobturator surgical articles and methods |
US7771345B1 (en) * | 2002-12-03 | 2010-08-10 | O'donnell Pat D | Surgical instrument for treating female urinary stress incontinence |
US20050149156A1 (en) * | 2003-12-24 | 2005-07-07 | Imad Libbus | Lead for stimulating the baroreceptors in the pulmonary artery |
US20050228346A1 (en) * | 2004-04-09 | 2005-10-13 | Cook Vascular Incorporated | Modular hemostatic valve |
US7319905B1 (en) * | 2004-11-30 | 2008-01-15 | Pacesetter, Inc. | Passive fixation mechanism for epicardial sensing and stimulation lead placed through pericardial access |
US20060241733A1 (en) * | 2005-04-25 | 2006-10-26 | Cardiac Pacemakers, Inc. | Atrial pacing lead |
US20070043416A1 (en) * | 2005-08-19 | 2007-02-22 | Cardiac Pacemakers, Inc. | Implantable electrode array |
US20070179559A1 (en) * | 2006-01-31 | 2007-08-02 | Medtronic, Inc. | Electrical stimulation to alleviate chronic pelvic pain |
US20070255341A1 (en) * | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Electrical stimulation of ilioinguinal nerve to alleviate chronic pelvic pain |
US20070253997A1 (en) * | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Drug delivery to alleviate chronic pelvic pain |
US20070253998A1 (en) * | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Drug delivery to iliohypogastric nerve to alleviate chronic pelvic pain |
US20070255333A1 (en) * | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Neuromodulation therapy for perineal or dorsal branch of pudendal nerve |
Cited By (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090036946A1 (en) * | 2001-11-29 | 2009-02-05 | American Medical Systems, Inc. | Pelvic disorder treatments |
US20090043356A1 (en) * | 2006-03-03 | 2009-02-12 | Ams Research Corporation | Electrode Sling for Treating Stress and Urge Incontinence |
US8195296B2 (en) | 2006-03-03 | 2012-06-05 | Ams Research Corporation | Apparatus for treating stress and urge incontinence |
US9889298B2 (en) | 2006-03-03 | 2018-02-13 | Astora Women's Health, Llc | Electrode sling for treating stress and urge incontinence |
US20070219606A1 (en) * | 2006-03-14 | 2007-09-20 | Boston Scientific Scimed, Inc. | Heatable sling support for an anatomical location |
US8170686B2 (en) * | 2006-03-14 | 2012-05-01 | Boston Scientific Scimed, Inc. | Heatable sling support for an anatomical location |
US20070265675A1 (en) * | 2006-05-09 | 2007-11-15 | Ams Research Corporation | Testing Efficacy of Therapeutic Mechanical or Electrical Nerve or Muscle Stimulation |
US8160710B2 (en) | 2006-07-10 | 2012-04-17 | Ams Research Corporation | Systems and methods for implanting tissue stimulation electrodes in the pelvic region |
US8311647B2 (en) | 2007-01-30 | 2012-11-13 | Cardiac Pacemakers, Inc. | Direct delivery system for transvascular lead |
US8412350B2 (en) | 2007-01-30 | 2013-04-02 | Cardiac Pacemakers, Inc. | Neurostimulating lead having a stent-like anchor |
US9427573B2 (en) | 2007-07-10 | 2016-08-30 | Astora Women's Health, Llc | Deployable electrode lead anchor |
US8774942B2 (en) | 2007-07-10 | 2014-07-08 | Ams Research Corporation | Tissue anchor |
US9539433B1 (en) | 2009-03-18 | 2017-01-10 | Astora Women's Health, Llc | Electrode implantation in a pelvic floor muscular structure |
US8380312B2 (en) | 2009-12-31 | 2013-02-19 | Ams Research Corporation | Multi-zone stimulation implant system and method |
US10959840B2 (en) | 2010-01-20 | 2021-03-30 | Micro Interventional Devices, Inc. | Systems and methods for affixing a prosthesis to tissue |
US9050065B2 (en) | 2010-01-20 | 2015-06-09 | Micro Interventional Devices, Inc. | Tissue repair implant and delivery device and method |
US9138211B2 (en) | 2010-01-20 | 2015-09-22 | Micro Interventional Devices, Inc. | Tissue repair implant and delivery device and method |
US10743854B2 (en) | 2010-01-20 | 2020-08-18 | Micro Interventional Devices, Inc. | Tissue closure device and method |
US9427220B2 (en) | 2010-01-20 | 2016-08-30 | Micro Interventional Devices, Inc. | Tissue repair implant and delivery device and method |
US10058314B2 (en) | 2010-01-20 | 2018-08-28 | Micro Interventional Devices, Inc. | Tissue closure device and method |
US9980708B2 (en) | 2010-01-20 | 2018-05-29 | Micro Interventional Devices, Inc. | Tissue closure device and method |
US9220887B2 (en) | 2011-06-09 | 2015-12-29 | Astora Women's Health LLC | Electrode lead including a deployable tissue anchor |
US20160089531A1 (en) * | 2011-06-09 | 2016-03-31 | Astora Women's Health, Llc | Electrode lead including a deployable tissue anchor |
WO2013036399A3 (en) * | 2011-09-08 | 2013-06-27 | Ams Research Corporation | Implantable electrode assembly |
US9731112B2 (en) | 2011-09-08 | 2017-08-15 | Paul J. Gindele | Implantable electrode assembly |
US11648410B2 (en) | 2012-01-26 | 2023-05-16 | Bluewind Medical Ltd. | Wireless neurostimulators |
US11278719B2 (en) | 2012-12-06 | 2022-03-22 | Bluewind Medical Ltd. | Delivery of implantable neurostimulators |
CN105246417A (en) * | 2013-03-15 | 2016-01-13 | 微介入设备公司 | Tissue closure device and method |
WO2014146000A3 (en) * | 2013-03-15 | 2014-11-06 | Micro Interventional Devices, Inc. | Tissue closure device and method |
US10780275B2 (en) | 2015-04-17 | 2020-09-22 | Mudjala Medical Pty Limited | Implantable neuro-stimulation device |
EP3283164A4 (en) * | 2015-04-17 | 2019-01-09 | Mudjala Medical Pty Limited | An implantable neuro-stimulation device |
WO2016168485A1 (en) | 2015-04-17 | 2016-10-20 | David Robinson | An implantable neuro-stimulation device |
US20190060642A1 (en) * | 2015-10-15 | 2019-02-28 | Spr Therapeutics, Inc. | Apparatus and method for positioning, implanting and using a stimulation lead |
US11413450B2 (en) * | 2015-10-15 | 2022-08-16 | Spr Therapeutics, Inc. | Apparatus and method for positioning, implanting and using a stimulation lead |
US11896820B2 (en) | 2015-10-15 | 2024-02-13 | Spr Therapeutics, Inc. | Apparatus and method for positioning, implanting and using a stimulation lead |
US11612747B2 (en) | 2015-11-09 | 2023-03-28 | Bluewind Medical Ltd. | Optimization of application of current |
CN106693173A (en) * | 2015-11-12 | 2017-05-24 | 青风医疗有限公司 | Inhibition of implant migration |
US11439833B2 (en) | 2016-11-23 | 2022-09-13 | Bluewind Medical Ltd. | Implant-delivery tool |
US11400299B1 (en) | 2021-09-14 | 2022-08-02 | Rainbow Medical Ltd. | Flexible antenna for stimulator |
Also Published As
Publication number | Publication date |
---|---|
US20120095478A1 (en) | 2012-04-19 |
AU2010226813B2 (en) | 2013-05-02 |
EP2974769B1 (en) | 2017-09-27 |
AU2010226813A1 (en) | 2011-10-20 |
US8774942B2 (en) | 2014-07-08 |
EP2408515B1 (en) | 2015-07-15 |
WO2010107751A3 (en) | 2010-11-18 |
EP2974769A2 (en) | 2016-01-20 |
EP2974769A3 (en) | 2016-04-13 |
US20120310317A1 (en) | 2012-12-06 |
EP2408515A2 (en) | 2012-01-25 |
WO2010107751A8 (en) | 2011-04-21 |
WO2010107751A2 (en) | 2010-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8774942B2 (en) | Tissue anchor | |
US20090012592A1 (en) | Tissue anchor | |
US8406901B2 (en) | Sutureless implantable medical device fixation | |
US5376108A (en) | Electrode lead anchoring apparatus and method employing dual suture collars | |
EP2024013B1 (en) | Implantable medical lead assemblies with delivery tether | |
US6434431B1 (en) | Intramuscular medical electrical lead with fixation member | |
US9827426B2 (en) | Systems and methods for fixating transvenously implanted medical devices | |
US7343202B2 (en) | Method for affecting urinary function with electrode implantation in adipose tissue | |
US20030028232A1 (en) | Method of lmplanting a medical electrical lead | |
US7725198B2 (en) | Implantable medical lead assemblies with delivery tether | |
US7565198B2 (en) | Systems and methods for bilateral stimulation of left and right branches of the dorsal genital nerves to treat dysfunctions, such as urinary incontinence | |
US7187982B2 (en) | Medical electrical lead anchoring | |
US8244371B2 (en) | Pancreas lead | |
US20060155353A1 (en) | Spring fixation mechanism for epicardial leads | |
US20110270340A1 (en) | Two-Stage Delivery Systems and Methods for Fixing a Leadless Implant to Tissue | |
US20110270339A1 (en) | Two-Stage Delivery Systems and Methods for Fixing a Leadless Implant to Tissue | |
JP2015510790A (en) | System and method for securing an implant to tissue | |
EP2295109A2 (en) | Tissue anchor | |
AU2013209374B2 (en) | Implantable device and tissue anchor | |
AU2015202998B2 (en) | Implantable device and tissue anchor | |
AU2016225794B2 (en) | Implantable device and tissue anchor | |
US20210085966A1 (en) | Implantable medical lead including fixation ridge |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: AMS RESEARCH CORPORATION,MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LUND, ROBERT E.;BUYSMAN, JOHN JASON;REEL/FRAME:023400/0770 Effective date: 20091021 |
|
AS | Assignment |
Owner name: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRA Free format text: SECURITY AGREEMENT;ASSIGNOR:AMS RESEARCH CORPORATION;REEL/FRAME:026632/0535 Effective date: 20110617 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: AMS RESEARCH CORPORATION, MINNESOTA Free format text: RELEASE OF PATENT SECURITY INTEREST;ASSIGNOR:MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT;REEL/FRAME:032380/0053 Effective date: 20140228 |